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ABSTRACT

CHARACTERIZATION OF A MULTIPLE ANTIBIOTIC RESISTANT FACTOR
FROM PROTEUS MIRABILIS
A Proteus mirabilis isolate associated with nosocomial urinary
tract infection was obtained from the clinical microbiology laboratory at Hines Veterans Administration Hospital.

The isolate, strain

2138, was resistant to at least ampicillin (Ap), carbenicillin (Cb),
gentamicin (Gm), tobramycin (Tm), kanamycin (Km), neomycin (Nm),
streptomycin (Sm), colistin (Cs), cephalothin (Cl) and tetracycline
(Tc).

Neutral sucrose gradient sedimentation of plasmid DNA isolated

from strain 2138 revealed the presence of three size classes of
plasmids, designated pFLlOOlO, pFL10020, and pFL10030.

The molecular

weights of the plasmids, calculated from contour length measurements
of electronmicrographs, were 90 X 10 6 , 5 X 10 6 , and 27 X 106 respectively.

A resistance phenotype of Ap, Cb, Gm, Tm, Km, Sm and Cl

was transferred to Escherichia coli J53-l via conjugation with strain
2138.

A single plasmid species having a molecular weight of 90 X 10

was isolated from the transconjugate J53-l (pFLlOOlO).

Isolated

plasmid species from strain 2138 were used to transform

~·

to antibiotic resistance.

6

coli Cl200-l

No detectable transfer of antibiotic re-

sistance occurred with the pFL10030 DNA, and only Ap and Cb resistance
was transferred using pFL10020 DNA.

Successful transfer of the

resistance phenotype of Ap, Cb, Gm, Tm, Km, Sm, and Cl to strain
iv

Cl200-l was achieved using pFLlOOlO DNA.

Agarose gel electro-

phoresis of partially purified plasmid DNA from strain 2138 and the
transformant Cl200-l (pFLlOOlO) showed a single plasmid species in
the transformant that co-migrated with pFLlOOlO from strain 2138.
The host range of the pFLlOOlO plasmid was investigated.

The plasmid

was transferred by conjugation to several genera of the Enterobacteriaceae and to the non-Enterobacteriaceae species, Pseudomonas
aeruginosa.

However, the plasmid did not transfer to the unrelated

species Agrobacterium tumefaciens, or to some of the Enterobacteriaceae
species tested.
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CHAPTER I
INTRODUCTION
A.
1.

REVIEW OF RELATED LITERATURE

Historical Perspective
The discovery of the 'IDiracle drug" (27) penicillin in 1941, and

subsequent antibiotics in the last forty years has revolutionized
medicine by drastically reducing morbidity and mortality from microbial
disease (21). Unfortunately, the versatility of microorganisms in
their adaptive capabilities has presented a formidible array of defenses against antibiotics.

The acquisition of multiple antibiotic

resistance by the Enterobacteriaceae and related gram-negative
organisms has become a significant problem in modern medicine.
Knowledge of drug resistant microorganisms is as old as chemotherapy itself.

In 1907, Paul Ehrlich (21) gave the first detailed

report of Trypanosome brucei which became resistant to the trypanocidal activity of paraosaniline (arsenic) after repeated exposure to
the drug.

Subsequently, with the introduction of each anti-microbial

agent came evidence of microbial resistance to its inhibitory
actions.
Attempts to explain this phenomenon led to two prevalent
theories.

One view held that the resistant cells developed by

spontaneous mutation independant of drugs and were selected by their
use.

The opposing view held that the resistant cells were the adap-

tive product of interaction between the drug and bacterial cell.

1

2

In 1943, Luria and Delbruck (64) established the fluctuation
analysis which provided a statistical method to determine the probability distribution of the number of resistant bacteria to be expected on the hypothesis of mutation.

Application of this method to

penicillin resistance in Staphylococcus by Demerec (20) indicated that
the resistance arose by spontaneous mutation where the drug acted as a
selective agent.

Further use of replica plating proved that drug

resistant mutants appeared spontaneously before exposure to the drug,
thus confirming the hypothesis of spontaneous mutation.
Outbreaks of Shigellosis in post war Japan challenged this theory.
Initially, Shigella dysenteriae responded to sulfanalamide treatment,
but the effectiveness of the drug waned after five years with the
emergence of sulfanalamide resistant Shigella strains.

The intro-

duction of newer antibiotics including streptomycin, tetracycline and
chloramphenicol, initially circumvented the problem.

However, within

seven years, clinical isolates were found to be resistant to each
antibiotic, and some multiply resistant to all of the antibiotics used
(110).

Since the frequency of spontaneous mutation to resistance to

one drug is small, 10- 7 to 10-8 (21), and independent of that to
another antibiotic, the frequency of spontaneous mutation to resistance to all four antibiotics simultaneously would be less than l0(71).

28

Given this probability, the occurrence of multiply resistant

Shigella dysenteriae and Escherichia coli from the same patient led
the Japanese microbiologists to the conclusion that sets of resistant
genes were conferring resistance to several antibiotics simultaneously

and were being transferred en bloc between bacteria of the same and

3

different species (106).
Genetic exchange among bacteria had been previously demonstrated
(75).

It had been established that bacteria could transfer genetic

information by transformation (60) in which the deoxyribonucleic acid
(DNA) extracted from cells of one strain could induce heritable
changes in cells of another, transduction (78) in which bacterial DNA
is carried by a phage vector to another cell, and conjugation (61)
in which genetic material is transferred through direct cell to cell
contact.
In 1959, Akiba and co-workers (1) and Ochiai and co-workers (85),
independently demonstrated the transfer of multiple resistance traits
from Escherichia coli to Shigella dysenteriae.

In 1960, Mitsuhashi and

associates (74) demonstrated that the drug resistance was not mediated
by filterable agents, was independant of chromosomal transmission, and
could be spontaneously lost.

Watanabe and Fukasawa (112) confirmed

that the transfer of drug resistance was mediated by cell to cell contact by use of the interrupted mating technique.

These workers hypoth-

esized that the resistance factors were carried on an episome termed
the resistance transfer factor (RTF) having autonomous replication and
being separate from F factors.

The term R factor was proposed by

Mitsuhashi in 1960 and was adopted to describe the postulated episomes.
Recently, the suggestion was made to supplant this term with the more
acceptable designation, R plasmid (83).
Simultaneous to the Japanese study came worldwide reports of R
plasmids isolated in several gram-negative species resistant to

4
sulfanalamide, streptomycin, tetracycline and chloramphenicol and
other antibiotics in an array of combinations.

Occurrence of multiply

resistant clinical isolates has increased steadily to become a major
medical concern (74).

These vast numbers of R plasmids have been

given various designations.

The term R plasmid is currently accepted

to designate a plasmid that carries genetic information for resistance
to antibiotics and/or other antibacterial drugs.

A resistant donor is

a bacterial strain that is capable of stably transferring resistant
genes, usually by conjugation, to a recipient strain and is referred to
as the R donor (83).
2.

Physical Characterization of Plasmids
a.

Chemical Composition
Plasmid molecules have been isolated and shown to consist of

double stranded deoxyribonucleic acid (DNA)(23).

Visualization with

the electron microscope (111) has revealed that plasmids exist as covalently closed circular (CCC) DNA molecules (111).

The molecular mass

of plasmids may vary from less than 106 to greater than 108 daltons,
with an average size of 6 x 106 daltons.

R plasmids may carry as many

as 100 genes, including traits other than drug resistance (8).
The inherent bouyant density of plasmid DNA, or mean base composition, is a consistent characteristic of a plasmid and can be used
to separate plasmids of differing densities from each other (19, 66).
A more specific measure of the evolutionary relatedness of plasmids
can be determined by DNA-DNA hybridizations and heteroduplex analysis
(47, 13).

The latter method has been useful for mapping insertions,

5

deletions and duplications in plasmid DNA molecules (44).
b.

Dissociation and Reassociation of Composite R Plasmids
Many R plasmids are composite structures consisting of resis-

tance transfer factor (RTF) and resistance determinants (r-determinants) components, each of which may be capable of autonomous replication under certain growth conditions,
Anderson and Lewis (3) were the first to observe that R plasmids may exist as multiple replicons which can dissociate and reassociate depending upon host species and culture conditions.

In

their system, the transfer factor, designated Delta, was found to
transfer independently of the resistance traits.

When Delta was

transferred into a cell having resistance traits to sulfonamides and
streptomycin, but lacking transfer capability, the plasmids reformed
and transferred both Delta and the resistance traits to a recipient.
This provided the basis for the resistance mobilization test Anderson
developed to detect the presence of transfer factors in other wild type
strains (2).
Anderson (2) classified plasmids into two groups:

Class 1 and

Class 2, which were also designated by Clowes (73) as plasmid cointegrate and plasmid aggregate, respectively.

In Class 1 plasmids,

the resistance determinants and the transfer factor farm a covalently
bonded complex which is maintained and transferred as a single linkage
group.

In Class 2 plasmids the resistance determinants and the

transfer factor exist as discrete plasmids, but are transferred together by an unknown mechanism, probably other than covalent linkage.

6
Guerry et al. (34) demonstrated that some plasmids were capable of both

Class 1 and Class 2 transfers and that the host plays a significant
role in plasmid organization.
The Anderson model proved inadequate in explaining the molecular nature of dissociated plasmids found in other species of Enterobacteriaceae, and there remains a controversy surrounding the proposed
models for dissociation.

The plasmid R-NRl (also designated

R~22and

R-100) confers resistance to sulfonamides, streptomycin, ampicillin and
tetracycline.

Analysis has shown the plasmid isolated from

!·

coli

to have a molecular mass of 60 x 10 6 daltons and a bouyant density of
1.711 g/cc.

However, when isolated from Proteus mirabilis this is not

the case.
In the P. miribilis host, multiple R plasmid DNA bands were
observed in cesium chloride density gradients when host cells were
cultured in drug-containing media (73).

Rownd (93) has shown that the

molecular mass, density and copy number of plasmids depend upon the
conditions under which the Proteus cells are cultured.

When cultured

in a drug-free medium, R-NRl DNA propagated in Proteus forms a single
satellite band with a density of 1.712 g/cc and a mass of 63 x 10 6
daltons.

After prolonged growth of cells in medium containing any of

the drugs to which R-NRl conferrs resistance, except tetracycline, a
band of greater density, 1.718 g/cc, is observed.

If the plasmid DNA

is isolated during transition between these two density states, a
complex of molecules having a broad spectrum of densities between
1.712 and 1.718 g/cc was observed.

7
Proteus mirabilis containing a segregant of R-NRl was found to
be resistant to tetracycline but not to any other drugs.

Since the

trait was transmissible it was thought to contain the transfer factor
linked to the tetracycline gene and was designated RTF-Tc (95).

When

grown in medium containing tetracycline this strain revealed a single
satellite in cesium chloride gradients having an intrinsic bouyant
density of 1.710 g/cc and mass of 49 x 10

6

daltons (SO).

Isolation of

the segregant from cultures in back transition, i.e., shift from antibiotic medium to antibiotic-free medium, showed two peaks in cesium
chloride gradients corresponding to densities of 1.710 and 1.718 g/cc.
Table I summarizes the data.
Rownd (92) proposed the following model to explain the phenomenon.

The R-NRl plasmid consists of two component parts:

the

transfer factor linked to the tetracycline determinant (RTF-Tc) and
the r-determinants.

In drug-free medium, R-NRl exists as a single

species having a molecular mass of 63 x 10 6 daltons.

In drug-containing

medium, there is a selection for cells having a higher level of drug
resistance as these would grow faster.

The r-determinants are ampli-

fied by the dissociation of the composite R plasmid into individual
replicons.

The amplified r-determinants exist as poly-r-determinants

joined in tandem repeats (89), which combine with a single RTF-Tc to
form poly-r-determinant R plasmids.

The broad intermediate density

band found in back transition is indicative of varying copies of rdeterminants per molecule.

The small plasmid (14 x 10 6 daltons) seen

in back transition represents a single r-determinant as would be

Tab1e 1.
Molecular properties of plasmid R-NRl from cells cultured in different media.a

Culture
Conditions

CsCl Gradients
Satellite Bands

NRl

antibiotic
free

1

1. 712

NRl

antibiotic

1

1. 718

NRl

back
. i onb
trans1t

2

1. 710
1. 718

RTF-Tc

antibiotic
free

1

1. 710

Plasmid

a
b

Bouyant Density
(g/cc)

Countour Length
(].lm)

37.0

Molecular Mass
(daltons)

6

63

X

10

14-87

X

10

28.7
8.3

49
14

X
X

6
10
6
10

28.7

49

X

10 6

8.2 - 42.0

6

Data from Hashimoto and Rownd (36).
Cells originally grown in antibiotic containing medium then placed in antibiotic-free medium.

00

9
predicted from differences between the composite R-NRl and the RTF-Tc
molecular masses.
Falkow (23) contends that the large poly-r-determinants exist
separately more often than in tandem with the RTF-Tc and account for
the 1.718 g/cc peak in cesium chloride gradients and that during
stationary phase in Proteus, R-NRl exists as a dissociated molecule.
Cohen and Miller (12) support this view.

However, all investigators

unanimously agree that R-NRl can dissociate in Proteus hosts into
separate units of replication, that the smaller units contain most of
the drug resistance genes present in multiple copies, and that the
RTF linked to the Tc resistance gene is present in only a few copies.
The transition of R-NRl has not been observed in E. coli
harboring the plasmid which is resistant to very high concentrations
of drugs.

However, an increased number of copies of monomeric com-

posite R-NRl plasmids per cell were found (95).

Transition of R

plasmids does not occur with most species and seems to be a peculiarity of the host species which harbors the plasmid (34).

The behavior

of R-NRl in P. mirabilis is typical of several other R plasmids found
in this species.
c.

Plasmid Copy Number
The number of copies of a plasmid per cell (copy number) is

usually estimated by comparing the ratio of plasmid DNA to chromosomal
DNA with the ratio of their respective sizes (molecular masses) (94).
There is usually a constant ratio of plasmid DNA to chromosomal DNA
throughout the exponential phase of growth which indicates that there

10
is a fixed number of rounds of plasmid replication each division cycle
(50).

rhe number of rounds of plasmid replication is a characteristic

of each type of plasmid and is one of the features of the control of
its replication.

In order for a plasmid to be maintained stably in a

population of cells, there must be at least one round of plasmid
replication during each division cycle.

Many plasmids are under

stringent control, that is, only one to two copies exist per chromosome; others are under relaxed control having several copies per
chromosome.
By selecting for increased levels of drug resistance, it has
been possible to isolate R plasmid mutants which have an increased
number of copies per cell.

These mutants have been referred to as

round of replication (ROR) mutants, since they undergo an increased
number of rounds of replication during the bacterial division cycle
(55).

These ROR mutants have the same size as the wild type R plasmids,

showing that the number of copies of the drug resistance genes has not
been increased by the formation of multimeric structures, as in transition

in~·

d.

miribilis (SO).

Insertion Sequences
Insertion sequences (IS) are specific nucleotide sequences, of

800 base pairs or more, which have the ability to insert or excise
from a segment of DNA.

Initially discovered as "hotspots" for recom-

bination (55), they provide a recognition site or area of homology
between two genetic elements allowing for interaction.

These se-

quences (IS-1, IS-2, IS-3, etc.) have been located at the interfaces

11
between the RTF and r-determinants of· R-NRl and several composite R
plasmids (44).

This suggests that recombination between IS elements

may provide the mechanism by which an R plasmid can dissociate into
its individual replicons (90).
e.

Transposition
Mobility has been associated with several drug resistance

markers.

Foster and co-workers (28) attempted to introduce two in-

compatible plasmids, one conferring resistance to chloramphenicol but
not to tetracycline and the other with opposite traits, into a single
bacterium by selecting for transconjugates resistant to both antibiotics.

The stable derivatives that were isolated were found to

carry the tetracycline marker on the bacterial chromosome.

The unit

carrying the resistance marker was flanked by two inverted IS-3
elements (28).

The tetracycline marker comprised a mobile determinant

displaying the capacity for insertion and excision which was formerly
thought to be a property of the insertion sequences themselves (40).
This capacity has been described as translocation or transposition,
and the unit that is transferred has been termed a translocon or
transposon.

The tetracycline transposon has been designated Tn9

(formerly TnD).

Transposition has been shown to be independant of

the cellular recombination (rec) systems (5, 57, 100).
Subsequently, several transposons have been identified (90).

A

penicillinase producing transposon, Tnl, has been found in several R
plasmids.

Heteroduplex mapping has shown Tnl to be flanked by in-

verted repeats of less than 100 base pairs (40).

A transposon, Tn9,

12
coding for chloramphenicol deactivation has been isolated in which no
inverted repeats were detected.

It has been suggested that trans-

position may not necessarily involve IS elements (83).
It is not known if there is a common mechanism or a variety of
mechanisms for transposition of Tn and IS elements.

The functional

significance of the inverted repeats has not been elucidated, although
it has been suggested that they are a stabilizing factor (63).
Evidence does imply that insertion is not random.

However, selec-

tivity may be low, and excision has been known to cause deletions (41).
Mutagenesis of bacterial and plasmid genes by insertions of transposons has also been demonstrated (90).

The role of these genetic

elements in the evolution and reassortment of R plasmids is thought to
be significant (55).

The use of antibiotics may create selective

pressures that encourage the transposition of Tn-like elements onto
transfer factors, allowing for construction and evolution of the composite R plasmid.

A plasmid may acquire several r-determinants in this

manner becoming a multiply resistant plasmid.
3.

Genetic Characterization of Plasmids
a.

Replication
The most important property of an R plasmid is its ability

to replicate autonomously in the cytoplasm of the host cells.

The

autonomy of the plasmid has been demonstrated by isolation of discrete plasmid molecules.

Inhibition of plasmid replication achieved

by use of acridine dyes which do not affect cell growth provides
convincing evidence of the independance of plasmid replicons (113).
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Although plasmid replication is physically separate from the host
chromosome, the limited number of plasmid molecules per host chromosome (109) and the unique time in the cell cycle of plasmid replication
(117) suggest that cellular control exists.

Rownd (SO) has shown that

the number of plasmids per chromosome (copy number) varies with host
bacteria.

The plasmid R-NRl in

(single copy) while in
observed (79).

f·

~·

coli exhibits stringent control

mirabilis relaxed control (multicopy) is

Chromosomal mutations making plasmid replication

temperature sensitive have been characterized and support the view
that there exist cellular controls on independent plasmid replicons
(114).

Studies on plasmid replication indicate that one or more proteins
are required for the initiation of R plasmid replication, and that a
small pool of "initiator protein" is present in the cells during exponential growth.

Some plasmids require ribonucleic acid (RNA)

synthesis for replication while others, including R-NRl, do not (95).
b.

Incompatibility
The introduction of a second plasmid into a plasmid bearing

host may lead to the elimination of one plasmid, or segregation of
the plasmids in subsequent generations (19).

This phenomenon of

mutual exclusion is shown by most known plasmids regardless of copy
number and is a manifestation of relatedness of plasmids.

This

situation has permitted the assignment of plasmids to incompatibility
sets, of which there are at least 26 among the enteric bacteria and 11
among those of Staphylococcus aureus (84).
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Early models for incompatibility postulated that there is a
specific membrane attachment site essential for plasmid replication,
simular to that of the chromosome (14), and that competition for that
attachment site may be coupled with production of a specific inhibitor
of replication (43).

Novick and Hoppensteadt (84) consider incom-

patibility to be a complex phenomenon involving several different
plasmid genetic systems that either influence or determine autonomous
incompatibility and its specificity.

These determinants include the

replication origin, the mechanism controlling copy number and the
putative recognition system for partition (which may be considered
as a centromere analog).

There may be others, as yet unidentified.

According to Datta (16) plasmids are said to be incompatible
if a host cell harboring a plasmid is immune to infection with a
second plasmid.

Compatibility between the two is indicated by

retention by the host of both-incoming and resident plasmids.

In-

compatibility is a transitive phenomenon i.e., if A is incompatible
with B, and B with C, then A is incompatible with C.
compatibility is not a transitive phenomenon (84).

However,
The system of

classification into incompatibility groups has become inadequate due
to difficulties in establishing experimental standard recipients, lack
of distinguishable genetic markers on some plasmids and plasmidplasmid interactions (31).
Interestingly, a correlation has been demonstrated between incompatibility grouping and DNA relatedness.

Plasmids within an in-

compatibility group almost always show extensive DNA homology, whereas
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plasmids of different groups rarely show significant homology (24).
Although exceptions exist (24), extensive homology exists between
plasmids of incompatibility group W (98) and within other groups.
All the plasmids of this group determine different resistant patterns,
were detected in different bacterial genera and were isolated in
different parts of the world.

The DNA of each hybridized with that

of the others to at least 75% of its total length.

Electron micro-

scopy of heteroduplex molecules of these plasmids and their recombinants and deletion mutants, have permitted the identification
of the DNA loci encoding the various resistance genes (98).
c.

Chromosomal Integration
Although plasmids exist as extrachromosomal elements inde-

pendant of the host chromosome, some, termed episomes, have the ability
to integrate into the chromosome (74).

This ability is host specific.

For example, some plasmids behave as episomes in!· coli, but not in
P. mirabilis (80).
from the chromosome.

Some plasmids, once integrated, are able to excise
Abnormal excision may explain the presence in

plasmids of genes governing host cell functions such as lac genes
found in a Proteus plasmid (103).
d.

Plasmid-Plasmid Interactions
Crossing over and recombination occur between different plas-

mids allowing genetic exchanges and plasmid-plasmid interaction.

Re-

combinant plasmids have also been created in vitro by use of restriction endonucleases (105).

These can be reintroduced into the host

bacteria by the transformation process.

Although it is presumed that
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replication and integration of plasmids is similar to models for the
chromosome, the molecular mechanism has not been fully elucidated.
e.

Transmissibility
The ability of R plasmids to spread throughout a bacterial

population is a major medical problem.
occurs in three steps (76).

Conjugal transmissibility

First, the production of the pilus

(conjugal bridge) is thought to provide the attachment site between
donor and recipient cell.

Following the formation of the initial

specific contacts, many donor and recipient cells form wall to
contacts (76).

Second, the formation of specific contacts is thought

to trigger a set of
from the donor.
mobilization.

wall

metabolic events that lead to the exit of DNA

These events prepare the DNA for exit and are termed
There has been question as to the function of the pilus.

Some workers believe it to be merely a means of bringing the cells
into contact and not used for passage of DNA (111).

Others believe

that the DNA passes through the pilus to the recipient cell.

Re-

gardless, the DNA is transferred as a single linear strand which must
replicate and circularize in the recipient cell.

Lastly, the genetic

expression of the R plasmid phenotype in the recipient must occur.
Interestingly, bacteriophages have been isolated which adsorb only
to certain conjugation pili (68).
In addition to transmissible R plasmids, a large number of R
plasmids have been isolated in the Enterobacteriaceae and S. aureus
which cannot mediate their own transfer from cell to cell.

These non-

transmissible R plasmids usually confer resistance to one or two drugs,
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are present in multiple copies per cell, and have molecular masses of
only 5-10 megadaltons (95).

Several bacterial genera also harbor

transfer factors (sex factors) which do not carry drug resistance gene.
Nontransmissible R plasmids can be mobilized (transferred to a recipient cell) by sex factors, transfer factors, or by transmissible R
plasmids when both are present in thesamehost cell (2).

The mechanism

of transfer appears to involve covalent linkage between the nontransmissible plasmid and the transfer factor.

Transfer factors and

small nontransmissible R plasmids can co-exist within the same host
and not recombine, as is true for any two compatible plasmids (95).
f.

Host Range
Certain plasmids have the ability to infect a variety of un-

related bacterial strains, other plasmids are limited to a single host
strain or related host species.

The R plasmids found among the Entero-

bacteriaceae and related gram-negative species generally are transferrable within the group.

The frequencies of R plasmid transfer differ

considerably among the species and depend upon the specific donor and
recipient cells, mating conditions, and origin of the plasmid.
ally,

!·

Gener-

coli, Shigella, Citrobacter and Klebsiella Enterobacter

species are useful donors and recipients.

However, species of Proteus,

Salmonella and Serratia generally do not transfer plasmids at high
frequencies in mating experiments (22).
g.

Transduction
Generalized transduction provides an additional way of trans-

ferring genetic material from one bacterial parent to another.

The

agents active in transduction are phage-like particles that have en-

is
capsulated a fragment of bacterial DNA (81, 99).

The significance of

plasmid transduction in nature is uncertain, but it provides a useful
genetic tool.

In some cases all of the resistance traits and trans-

missibility can be transduced by phage, while, in other cases, only
certain genes are transduced.

The size of the DNA molecule that can

be incorporated into the phage capsule probably determines the number
of plasmid genes which are transduced.

This phenomenon of "trans-

ductional shortening" has been useful in determining the genetic
sequence of some plasmids (99).
In the transduction of an R plasmid conferring resistance to
sulfonamide, streptomycin, tetracycline and chloramphenicol to
Salmonella typhimurium using phage P-22 as vector, transductants received either sulfonamide-streptomycin-chloramphenicol resistance en
bloc or tetracycline alone.

Only in the latter case could the re-

sistance then be transmitted through conjugation (108).

In later ex-

periments with the same plasmid the resistant traits were segregated
in the transductants allowing for the construction of a genetic map
of the plasmid (110).

This indicated that the resistance genes are

indeed different and that multiple drug resistance is not some pleatrophic effect of a single gene.

The most important conclusion is that

the genes determining resistance and those determining conjugal ability
are distinctly separable.
4.

Molecular Basis of Drug Resistance
Bacterial resistance to a particular antibiotic or related series

of antibiotics depends on a single mechanism, although occasionally a
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combination of mechanisms may be found in the same organism (78).

The

most frequently found mechanism of resistance will be discussed here.
a.

Beta-Lactam Resistance
The most prevalent mechanism of resistance is conversion of

an active drug to an inert product by an enzyme found only in resistant bacteria.

The existence of genes coding for drug inactivating

enzymes in R plasmids of Enterobacteriaceae was first demonstrated
for enzymes hydrolyzing the beta-lactam drugs (17).

A single pre-

dominant plasmid-associated beta-lactamase was found in

gra~negative

R plasmids of wide taxonomic and geographical range, and was termed
"TEM-like" beta-lactamase (54).
In terms of physical properties, substrate specificity and
specific activity, most beta-lactamases fall into two general types:
the TEM type (also called type 1) and the 0 type (also called type 2).
The former type has a broader general activity on penicillins and
cephalosporins, but considerably less on oxacillin.
the opposite effect (39).

The latter has

The TEM type may be coded for by chromosomal

or plasmid genes and is associated with transposons.

The 0 type has

only been found associated with plasmids (22).
These beta-lactamases are capable of hydrolyzing the beta-lactam
ring of antibiotics rendering them inactive.

In the gram positive

bacteria the synthesis of beta-lactamase is induced by the presence
of the antibiotic and the enzyme is excreted, inactivating its substrate extracellularly (17).

Conversely, gram-negative cells synthe-

size the enzymes constitutively, but in smaller quantities than gram-

2J
positive cells, and the enzyme remains periplasmic (17).
A second, less common family of penicillin-inactivation enzymes
has been characterized.

The enzyme, an amidase, inactivates the drug

by hydrolyzing the CO-NH bond between the side chain and the 6-amino
group in the penicillin acid residue (22).

Enteric bacteria have

been found to elaborate this enzyme, but R plasmid mediated resistance
to penicillin has been solely associated with beta-lactamase activity
(54).
b.

Chloramphenicol Inactivation
The mechanism of R plasmid mediated chloramphenicol resistance

involves a drug-inactivation enzyme that catalyzes acetylation of
chloramphenicol in the presence of acetyl-coenzyme A.

The vast

majority of R plasmid-containing clinical isolates that are chloramphenicol resistant have been found to elaborate this constitutive
enzyme, chloramphenicol acetyl transferase (45).

Thus far the enzyme

has appeared to be reasonably homogeneous in all isolates examined
regardless of their bacterial host and geographical location (22).
However, there are significant differences in enzyme levels observed
among different R plasmid-containing chloramphenicol resistant isolates
when the same R plasmid is transferred from host to host.

As pre-

viously mentioned, transpositional activity has been associated with
chloramphenicol resistance (28).

This could well explain the observed

homogeneity of chloramphenicol acetyltransferase activity found in the
various unrelated species.
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c.

Aminoglycoside Resistance
The aminoglycosides constitute a large, diverse, but

structurally related family of antibiotics.

Gentamicin, tobramycin,

streptomycin, kanamycin and other aminoglycoside antibiotics are still
commonly employed against gram-negative infections.

The mechanism of

chromosomal resistance to streptomycin is associated with specific
alterations of the target site of the antibiotic on the 30S ribosomal component.
(77).

Such alterations prevent binding of the antibiotic

However, this type of resistance is rare among clinical iso-

lates (22).
Studies on the biochemical mechanisms of R plasmid-mediated
aminoglycoside resistance indicate that they are not associated with
ribosomal alteration, but rather with a remarkable number of enzymes
which modify the antibiotics (107).

Despite the variety of enzymes,

there are only three known classes of inactivating reactions.

The

antibiotics are inactivated by either N-acetylation, phosphorylation
or adenylylation of susceptible amino or hydroxyl groups, using
adenosine triphosphate (ATP) or acetyl coenzyme A as cofactors (18).
Most aminoglycoside antibiotics are subject to more than one inactivation reaction.

The enzymes are constitutively synthesized and are

retained within the bacterial cell (18).
Those enzymes involving phosphorylation of antibiotics are
termed the aminoglycoside antibiotic phosphotransferase enzymes.
Based on their physical properties and substrate specificity there
are three groups of enzymes in this class.

The first group called
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the kanamycin phosphotransferases has three types:

1) the first

inactivates kanamycin (Km), neomycin (Nm), ribostamycin (Rb),
paromycin (Pm), and lividomycin (Lv);
Km, Nm, Rb, Pm and butarosin (Bt);
Km, Rb, Bt and Lv.

2) the second inactivates

3) and the third inactivates

The second group contains only a single activity

ribostamycin phosphotransferase, which inhibits Rb action exclusively.
The third group contains two streptomycin (Sm) inactivating enzymes:
Sm-3'-phosphotransferase and Sm-6'-phosphotransferase (78).
Acetylation of aminoglycoside antibiotics is carried out by
the aminoglycoside antibiotic acetyltransferase enzymes.
three major groups of enzymes in this category.

There are

The first is the

Km-6'-N-acetyltransferase group of which four major types are known:
1)

the first inactivates Km and Nm; 2) the second inactivates Km,

Nm and gentamicin (Gm); 3) the third inactivates Km, Gm and
3'-4'-dideoxy kanamycin (Km-D); and 4) the fourth inactivates Km, Gm,
Km-D and amikacin (Ak).

The second group includes the aminoglycoside

3'-acetyltransferase I enzyme which inactivates Gm and sisomycin (Ss),
and aminoglycoside 3'-acetyltransferase II which inactivates Gm, Ss,
Km and tobramycin (Tm).

The third group of acetylating enzymes

contains aminoglycoside 2'-acetyltransferase which inhibits the action
of Gm, Nm, Km, Km-D, Rb, Lv and Bt (78).
There are four groups of enzymes known that effect the adenylylation of aminoglycoside antibiotics.

These are called the amino-

glycoside antibiotic adenylyltransferase enzymes.

They are 1) Sm-

adenylyltransferase which inactivates Sm and spectinomycin (Sp);
2) Sm-6'-adenylyltransferase which inactivates Gm, Km, Km-D and Tm;
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3) Gm-Km-2'-adenlylytransferase which inactivates Gm, Km, Km-D and Tm;
and 4) Tm-4'-adenylyltransferase which inactivates Tm, Km, Nm, Bt, Pm,
and Ak (78).
d.

Non-Enzymatic Resistance Mechanisms
Tetracycline resistance is probably the most common R plasmid-

mediated drug resistance found in nature (21).

Although the specific

mechanism whereby tetracycline is inhibited is not known, the drug is
probably blocked from entering the cell in sufficient concentrations to
inhibit ribosomal function.

The resistance determinant may code for a

new membrane protein which will not bind tetracycline.

Franklin and

Cook (29) have shown that the decreased uptake of the drug, and concomitantly the level of resistance, is appreciably increased in the
presence of tetracycline, suggesting that the inhibitor of tetracycline
is inducible.

There is no evidence for enzymatic inactivation or

modification of tetracycline, the resistance appears to be associated
with modification of cellular permeability of the drug.
Bacterial resistance to p-aminobenzenesulfonamide (sulfonylamide:
Sa) and its resistance has been described.

Observations that the drug

is neither destroyed nor modified by R plasmid-containing strains
suggest that resistance is due to decreased permeability of the cell
membrane to sulfonylamide (107).

Pato and Brown (88) have reported a

second type of resistance mechanism involving the sulfonylamide sensitivity of the enzyme dihydropteroate synthetase, which decreases in
accordance with an increase in Sa resistance.

Recent findings indi-

cate that the most general mechanism of high Sa resistance in gramnegative bacteria carrying R plasmids is due to the production of Sa-
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resistant dihydropteroate synthetase which differs from Sa-sensitive
enzyme produced by sensitive strains in Sa-susceptibility and in various
enzymological properties (78).
Bacterial drug resistance may be affected by changes in the
target site of the drug as mentioned for streptomycin resistance (45,
77).

Streptomycin resistance is caused by mutation of the S-12 pro-

tein of the ribosome which is the ultimate binding site for the antibiotic.

It is uncertain whether the mutation is induced by the

presence of the antibiotic.

It may result from use of an alternate

pathway selected after elimination of the primary pathway by streptomycin.

Of clinical significance are two forms of antibiotic resistant

enzymes, a naladixic acid resistant DNA gyrase and a rifampicin resistant RNA polymerase, both of which are examples of alterations of
target sites of antibiotics (45).
5.

Versatility of Plasmids
R plasmids are known which also mediate resistance to a number of

heavy metals, and ultraviolet irradiation.

Mercury resistance appears

to be inducible and associated with enzymatic catalysis (104).

The

mechanism for resistance to other heavy metallic ions, such as nickle
or cobalt, has not yet been elucidated (22).
Other plasmids are known which contain genetic determinants
unrelated to those for antibiotic resistance.

Col plasmids have been

discovered which confer colicinogency to Escherichia coli (42).
Degradative plasmids found in some species of Pseudomonas have been
characterized by their ability to code for enzymes that catabolize a
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great variety of unusual organic compounds by special metabolic pathways (42).
virulence of

Plasmids have been described which contribute to the
~·

coli by coding for production of alphahemolysins (Hly

plasmids) (100), enterotoxins (Ent plasmids) and surface antigens
(101).

Many gram-negative species harbor plasmids which do not carry

genes which can be phenotypically detected.

These cryptic plasmids can

only be detected through DNA isolation techniques (33).
6.

Gram-Positive Bacterial Plasmids
Plasmids have been isolated from species of Staphylococcus aureus

which produce beta-lactamase and other antibiotic inactivating enzymes
(82).

Although multiple-resistant strains have been isolated, it has

been found that each resistant determinant is usually located on a
different plasmid, and that the plasmids, in general, tend to be
smaller than those found in gram-negative species (45).

It was

originally thought that Staphylococcal plasmids were non-conjugal (22),
and although conjugation has been demonstrated it is considered a rare
occurrence (48).

The facts indicate that transduction with phage

lysates is mainly responsible for acquisition of drug resistance and
for the wide and rapid distribution of multiple resistance among
Staphylococci (48).

The plasmids may exist in high copy number, up to

25 copies per cell, which accounts for resistance to high levels of
antibiotics (48).
Multiple resistance plasmids have been isolated from species of
Streptococcus faecalis.

These have been shown to effect their own

transfer through the conjugation process.

Additionally, intergenic
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conjugal transmission has been demonstrated between the streptococci
and Lactobacillus species (49).

Conjugation among streptococcal

species is no longer considered a rare occurrence (49).

B.

INTRODUCTION TO THIS STUDY

The prolongation of life in persons with severe underlying
diseases that affect host defenses combined with the increasing use of
corticosteroids, immunosuppressive agents, cytotoxic drugs and antibiotics has resulted in the emergence of a relatively new spectrum of
infectious diseases.

Ubiquitous previously saprophytic commensals,

rarely causing infection in the normal host, are now recognized with
increasing frequency in patients with compromised defense mechanism
(7).

Infections with such organisms pose a dilemma not only in

diagnosis, because of their relative newness, but in therapy due to
their increased resistance to conventional antibiotic treatment (52).
The Center for Disease Control reported in 1978 that 3.6% of
patients hospitalized in the United States acquired nosocomial infections.

More than half of those infections either caused or con-

tributed to the death of the patient (HEW Publication (CDC) No. 788257).

Of the nosocomial infections that year, nearly half were

caused by members of the Enterobacteriaceae and related bacterial
species.

These organisms, termed conditional pathogens, are usually

present in normal flora and spread by human contact (98).
This study initially began as an investigation into the increasing frequency of nosocomial infections at Hines Veterans Hospital
at Hines, Illinois (65).

Several strains of Proteus mirabilis isolated

from clinical specimens were found to be clinically resistant to
27
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gentamicin and ampicillin which were commonly used in their treatment.
one isolate, Proteus mirabilis 2138, was chosen as the subject for this
study because of its resistance to these and several other antibodies.
This study was undertaken to elucidate the basis of this multipleantibiotic resistance, specifically to determine whether R plasmids were
involved, and if so, whether they were capable of being transferred to
other gram-negative conditional pathogens.
are

The aims of this research

1) to study the genetic nature of multiple antibiotic resistance

in Proteus mirabilis 2138; 2) to characterize the molecular nature of
that genetic determinant; and 3) to determine the transmissibility and
host range of the antibiotic resistance pattern.

CHAPTER II
MATERIALS AND METHODS
1.

Bacterial Strains
The bacterial strains used in this investigation are listed in

Table II.

Proteus mirabilis 2138 was isolated at Hines Veterans

Administration Hospital at Hines, Illinois and found to be resistant
to both gentamicin and ampicillin/carbenicillin in routine laboratory
screening.

With the exception of the Agrobacterium tumefaciens strains

which were grown at 30 C, all bacteria were grown at 37 C.

For the

purpose of counter selection, spontaneous rifampicin resistant mutants
of certain bacterial strains were isolated.

This was achieved by

innoculating sensitive cells on nutrient agar plates containing 5
rifampicin.

~g/ml

Surviving colonies were picked and restreaked onto plates

containing progressively higher concentrations of the drug (10, 15, 50,
75, 100 and 200

~g/ml)

until the clones were able to grow well on

nutrient agar plates containing 200

~g/ml

rifampicin.

The resistant

clones were maintained in this manner.
2.

Chemicals
All chemicals used were of the highest quality available and not

further pruified.
Nuclear.

Radioactive compounds were purchased from New England

Enzymes and amino acids were purchased from Sigma Chemical

29

30
Table

II~

Standard bacterial strains used.

. a
Stra1n
Escherichia coli
J53
J53-l
Cl200
Cl200-l
CSH-K-12
Proteus mirabilis
2138
Pml5

.

.

Re 1 evant ch aracterl.stl.cs

b

K-12 pro met FA+
K-12 pro met F-A.+ Rmr

Origin

C his met F- A.Chis met F-A.- Rmr
Prototroph

S. Falkow
This laboratory
E. W. Six
This laboratory
M. Stodolsky

Hospital isolate, prototroph
Leu- Trp- Thy- Gal- Nia-

Hines
V.A. Hospital
R. H. Rownd

Agrobacterium
tumefaciens
B6-806
15955

This laboratory
This laboratory

Enterobacter cloacae
ATCC 23355

Prototroph

w.

Yo tis

Klebsiella pneumonia
ATCC 27730

Prototroph

w.

Yo tis

Proteus vulgaris
ATCC 6380

Prototroph

w.

Yo tis

Serratia marcescens
ATCC 8100

Prototroph

w.

Yo tis

Pseudomonas aeruginosa
PA038

leu-38 FP2-

R. Olsen

Salmonella typhimurium
TA1637

LT2 his ade

H.

Asp- Asn- Leu- Ile- ValTrp- His- Nia-

R. J.
Christiansen

Shigella flexneri
SFl
a
b

K-12, serotype K-12;
Asn cine,
Val Gal -

w.

Taber

C, serotype C.

asparagine, Asp - aspartic acid, His - histadine, Ile - isoleuLeu - leucine, Met - methionine, Pro - proline, Trp - tryptophan,
valine, Ade - adenine, Nia - niacin, Thy - thymidine and
galactose.
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Company, agarose (HGT) was purchased from SeaKem,

Pharmaceutical

companies provided many of the antibiotics used for this study.
3.

Media
Complex media used were:

nutrient agar (NA), containing per

liter 8.0 g Nutrient Broth (Difco) and 12.0 g agar (Difco); L Broth,
containing per liter S.O g yeast extract (Difco), 10.0 g tryptone
(Difco) and S.O g NaCl; MacConkey's Agar (Difco); and Mueller-Hinton
Agar (M-H) (Difco),
Minimal medium for Escherichia coli

(&~)

contained per liter:

3.0 g K2HPo , 1.0 g KH Po , S.O g NH Cl, 1.0 g NH No , 2.0 g Naso
4
2 4
4
4 3
4
(anhydrous) and 0.1 g MgS0 ·7H o (86).
4
2
Minimal medium for Pseudomonas aeruginosa strains (PM) contained
per liter:

6.0 g Na HPo , 2.0 g KH Po , 0.1 g MgS0 ·7H 0, 1.0 g NaCl
2
4
2 4
2
4

and S.O g Na

c HSo 7 (sodium citrate) (86).
3 6

Agrobacterium tumefaciens strains were grown in minimal medium
which contained per liter:

1.0 g Na HPo , 3.0 g KH Po , 0.3 g Mgso ,
2
4
2 4
4

1.0 g NH Cl, 0.2 g KCl, 0.2 g CaC1 and 0.1 g Fe so (62).
4
2
2 4
Minimal medium phosphate buffers and salts were made separately
as 20X stock solutions which were autoclaved and added to sterile
dH 2o to achieve lX concentrations.

Sterile glucose (SO%) was added

to achieve a final concentration of 0.2%.
strains SO
or 10

~g/ml

~g/ml

of the appropriate amino acids, 2S

nicatinamide were added.

tained 1.2% agar.

To sustain auxotrophic
~g/ml

nucleoside

Solidified minimal medium con-
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4.

Determination of Minimal Bactericidal Concentrations (MBC)
The minimal concentration of an antibiotic necessary to kill a

suspension of cells (MBC) was determined by the tube dilution technique.
8
Tubes containing 10 ml of serially diluted antibiotic (10- 1 - 10 ) in L
broth were innoculated with 1 ml of a bacterial suspension (approximately 50 Klett units, Klett-Summerson Photoelectric colorimeter model
800-3, No. 66 red filter) and incubated overnight.

A 0.1 ml sample

from each tube was plated on NA and incubated overnight.

The lowest

dilution of antibiotic that yielded no growth on the NA plate was
given as the MBC.
5.

Determination of the Antibiotic Resistance Spectrum
The Kirby-Bauer disk diffusion technique (69) was used to deter-

mine the antibiotic resistance spectrum.

Onto Mueller-Hinton plates

confluently streaked with a bacterial suspension were placed disks
containing antibiotics.

The plates were incubated at 37 C for 24 h.

Zones of inhibition of bacterial growth around each disk were measured
and compared to standard charts relating zone diameter to antibiotic
resistance.

Results were recorded as resistant (R) or sensitive (S).

Donor, recipient, transconjugate and transformant strains were tested
for resistance to the following drugs:

gentamicin

(Gm), tobramycin

(Tm), neomycin (Nm), kanamycin (Km), streptomycin (Sm), tetracycline
(Tc), ampicillin (Ap), carbenicillin (Cb), cephalothin (Cl), colistin
(Cs) and rifampicin (Rm).
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6.

Genetic Experiments
a.

Conjugations
Precultures of donor and recipient cells in 10 ml 1 broth

were grown overnight in a shaking incubator, diluted 1:10 with fresh
1 broth and grown to late exponential phase (Klett reading of 50-100).
Conjugation mixtures consisted of 1.2 ml fresh 1 broth, 0.2 ml donor
cells and 0.6 ml recipient cells.

Controls included 1.8 ml fresh 1

broth plus 0.2 ml donor cells, and 0.6 m1 recipient cells in 1.4 ml
fresh 1 broth.

The mating mixture and controls were incubated at

37 C with minimal agitation for 24 h.

The titer of imput donor cells

was determined by plating serial dilutions in triplicate on NA plates.
The plates were incubated for 24 h and the number of colonies counted.
The conjugation mixture and controls were centrifuged at
10,000 rpm for 10 min to pellet the cells which were then washed in
minimal medium lacking glucose and recentrifuged.

The washed cells

were resuspended in minimal medium, diluted and plated on selective
media.

A 0.1 ml sample of the mating mixture and each control were

plated in triplicate on selective media.

Additionally, the donor,

recipient and mixed cultures were each plated on minimal medium
lacking antibiotics, minimal medium containing antibiotics and on
nutrient agar.
(1-5 days).

The plates were incubated until growth was apparent

If no growth appeared after 7 days, negative results

were recorded.
Matings that failed to demonstrate detectable transfer of
antibiotic resistance traits after three trials were repeated using
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sterile nitrocellulose filter disks to concentrate the cells.

Pre-

cultures were grown and diluted and regrown as above, 5 ml aliquots
of donor and recipient cells were concentrated by vacuum suction onto
membrane filters (0.45

~

pore size, Millipore, Inc.) which were

transferred growth side up to NA plates.
were filtered likewise as controls.

Donor and recipient cultures

Following overnight incubation

the filters were placed in growth flasks containing 10 ml L broth and
swirled to resuspend the cells.

The cell suspensions were pelleted

by centrifugation, washed twice in minimal medium lacking glucose and
plated as previously described.
b.

DNA-Mediated Transformations
The method of Lederberg and Cohen (60) was used to transform

Escherichia coli strains with purified plasmid DNA.

An overnight

preculture of the recipient strain was used to innoculate 50 ml of
fresh broth.

The cells were grown to exponential phase, transferred

to a sterile, chilled centrifuge tube

and incubated on ice for 5 min.

The cells were pelleted by centrifugation for 10 min at 10,000 rpm,
the supernatant was discarded and the cell pellet resuspended in 25 ml
of ice cold 0.1

~

MgC1 2 •

The cells were transferred to a 30 ml cen-

trifuge tube, iced for 20 min and pelleted by centrifugation as before.
The cells were resuspended in 2.5 ml of ice cold 0.1

~

CaC1 2 and

transferred to a sterile test tube.
The transformation mixture contained 0.1 ml purified plasmid
DNA (50

~g/ml)

in TEN buffer (0.02 -M Tris-HCl, 0.001 -M EDTA, 0.02 M

NaCl, pH 8.0) to which 0.2 ml competant cells from above were added.
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Co~tro~s

had additional TEN buffer substituted for the DNA.

The mix-

tures were iced for 30 min, 'and then placed directly into a 42 C
waterbath for 2 min to enable uptake of DNA.

To 9.9 ml of pre-

warmed L broth, 0.1 ml of the transformation mixture or control was
added.

These cultures were incubated with shaking at 37 C for 90-120

min to allow full expression of the antibiotic resistance trait to be
selected.

Appropriate dilutions of the mixtures were plated on

selective media and incubated until colonies appeared.

To check the

sterility of the DNA and the viability of the cells, 0.1 m1 of each
was plated onto nutrient agar.
7.

Determination of Plasmid Stability
To· determine the stability of the plasmids in transconjugate

strains, 100 clones from each mating were picked onto nutrient agar
plates.

The clones were passed daily onto fresh media.

At two week

intervals, the clones were picked onto two additional sets of plates
containing either gentamicin (50

~g/ml)

or carbenicillin (100

~g/ml).

Those clones that grew on the nutrient agar plates, but failed to
grow on the gentamicin or carbenicillin plates were retested to
confirm their loss of resistance.
8.

Radiolabelling of Bacterial DNA
Overnight precultures of cells grown in minimal medium were used

to innoculate 30 m1 cultures of minimal medium supplemented with 0.2%
glucose, 0.5% casamino acids (Difco) and 300

~g/ml

enhance the incorporation of ( 3H)-thymidine (35).

deoxyadenosine to
At Klett readings
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of 10, 20, and 30, 0,3 ml of (3 H}-th~dine (New England Nuclear Corp,,
40-60 Ci/mmole, 1 mCi/ml) was added to the culture.

The cultures were

grown to a final Klett reading of 50-100 and the cells harvested by
centrifugation at 10,000 rpm for 10 min (Sorvall RC-5 centrifuge,
SS-34 rotor),

The cells were resuspended in minimal medium lacking

glucose, washed and centrifuged as before.

The cells were lysed and

the DNA isolated as described below,
9.

!solation of Extrachromosomal DNA
Several methods were used to isolate extrachromosomal DNA from

Proteus mirabilis 2138 and Escherichia £21! JS3-l(pFL10010) strains.
The methods vary according to-the susceptibility of the bacterial cells
to lysis and the size of the plasmid molecule being isolated.

Cells

were grown in L broth unless otherwise stated.
a,

Helinski Cleared Lysis
In a typical preparation (58), a 30 m1 bacterial culture

grown at 37 C to a cell density registering between 50-100 Klett units
was harvested by centrifugation, washed twice with cold (4 C) TES
buffer (0.05 M NaCl, 0.005 M EDTA, 0.05 M Tris-HCl, pH 8.0) and
pelleted by centrifugation at 4 C for 10 min at 10,000 rpm.
pellet was resuspended in 1 m1 cold 25% sucrose in 0.05
pH 8.0.

~

The

Tris-HCl,

After the addition of 0.2 m1 of lysozyme (Sigma Chemical Co.,

5 mg/ml in 0.25 M Tris-HCl, pH 8.0) the suspension was placed on ice
for 5 min.

Ethylenediamine-tetraacetic acid (EDTA, 0.4 ml, 0.25 M,

pH 8.0} was added to the cells followed by 5 min of incubation at
4 C.

Complete cellular lysis was accomplished by the addition of
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1.6 ~ o~ a detergent mtxture containing 1% Brij 58 and 0.4% sodium
deoxycholate in 0.0625 M EDTA, 0.05 M Tris~ HCl, pH 8.0.

After 5-10

min at room temperature the suspension became relatively clear and
viscous and was placed in a 30 ml centrifuge tube and centrifuged for
25 min at 18.500 rpm (Sorvall RC-5 centrifuge, SS-34 rotor).

The

supernatant containing the plasmid DNA was carefully removed to
minimize contamination with pelleted chromosomal DNA and subjected to
cesium chloride-ethidium bromide (CsCl-EtBr) density centrifugation
as described below.
b.

Guerry Method
A modification of the Helinski method by Guerry

~

al. (35)

was used to isolate plasmid DNA for agarose gel electrophoresis.
Bacterial cells were grown, harvested and treated with lysozyme and
EDTA as above.

Sodium dodecyl sulfate (SDS) was added to a final con-

centration of 1% to achieve complete cellular lysis.
~

After lysis, 4.0

NaCl was added to the viscous solution with gentle mixing to achieve

a final salt concentration of l M.

The lysates were stored at 4 C

overnight, after which they were centrifuged at 17.000 rpm for 30 min
at -10 C.

The aqueaus phase was removed, doubled in volume by the

addition of dH

o and prepared for agarose gel electrophoresis as

2

described below.
Plasmid DNA, partially purified by the Guerry method was prepared for agarose gel electrophoresis by the method of Meyers
(71).

The supernatant was treated with 20

~g/ml

~

al.

ribonuclease A

(bovine pancreas, Sigma Chemical Co., 1 mg/ml in 50 mM sodium acetate

3S

pH 5.0, heated at 90 C for 10 min) and incubated for 45 min in a 37 C
waterbath.

After RNase digestion, an equal volume of redistilled

phenol saturated with 0.05 M Tris-HCl, pH 7.5 was added, phases were
gently mixed and the emulsion centrifuged at 12,000 rpm for 20 min at
20

c.

The aqueous phase was removed.

extraction was repeated.

If it appeared cloudy the phenol

The interphases of all phenol extractions

were pooled and again extracted with phenol, and the aqueous layers
combined.

An equal volume of chloroform-isoamyl alcohol (24:1 v/v)

was added, carefully mixed and centrifuged as before to obtain a clear
aqueous phase.

The partially purified plasmid DNA solution was brought

to a final concentration of 0.3 M sodium acetate by the addition of
one-tenth volume of 3.0 M sodium acetate solution, and twice the volume of cold (-20 C) 95% ethanol was added to precipitate the DNA.
mixture was well mixed and stored at -20 C overnight.

The

The precipitated

DNA was pelleted by centrifugation at 12,000 rpm, 20 min, at -10 C.
The supernatant was decanted and the tube allowed to thoroughly drain.
The DNA was redissolved in 0.1 ml of buffer containing 0.03 M TrisHCl, 0.05 M NaCl, and 0.005 M EDTA, pH 8.0, and analyzed immediately
by agarose gel electrophoresis or stored at -20 C until ready for use.
c.

Currier Method
A modification of the Currier method (15) was used to isolate

large plasmids.

All steps were carried out at room temperature unless

otherwise stated.
500 ml of L broth.

An overnight preculture was used to innoculate

Cells were grown to a density corresponding to a

reading of 50-100 Klett units, and harvested by centrifugation.

The
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cells were

was~ed

twice in EM lacking glucose and resuspended in 49

ml of 0.05 M Tris-HCl, pH 8.0.

After thorough mixing, 1.0 ml of 1.0 M

EDTA, pH 8.0 was added to the cell suspension.

A solution of lysozyme

in TE buffer (0.05 M Tris~HCl, 0.02 M EDTA, pH 8.0) was added to
achieve a final concentration of 200

g/ml and the mixture was in-

cubated for 5 min in a 37 C waterbath.

Carefully, 2.5 ml of 20X SDS

solution was added to make 1% final concentration.

Incubation at 37 C

was resumed until a clear lysate of high viscosity was obtained
(10-60 min).
The lysate was sheared until it flowed evenly by several
passages through an 18 guage hypodermic needle attached to a 50 cc
syringe.

The DNA was denatured by adjusting the pH of the sheared

lysate to 12.1 - 12.4 by the dropwise addition of 3N NaOH with continuous stirring on a magnetic stir plate.

After 10 min of mixing,

the pH of the solution was brought to approximately 8.5 by the rapid
addition of 2.0

~

Tris-HCl, pH 7.0.

Stirring was continued for 3 min.

The lysate was adjusted to a final concentration of 3% (w/v) NaCl
by the addition of solid salt.
equilibrated with 3X SSC (0.15

An equal volume of redistilled phenol
~

NaCl, 0.015

~

trisodium citrate)

was added and the lysate mixture was stirred for 7 min fast enough to
mix the phases.

The lysate was centrifuged at 10,000 rpm for 10 min

and the aqueous phase removed to a clean flask without disturbing the
precipitate at the interphase.

A second extraction using an equal

volume of chloroform-isoamyl alcohol (24:1 v/v) proceeded likewise.
the aqueous phase a 0.02 volume of 1.0 M sodium phosphate buffer was

To
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added followed by the addition of 0.025 volume of 1.0 M magnesium
chloride.

The

~olution

was well mixed by swirling the flask.

A 0.7

volume of cold (-20Cl 95% ethanol was added while swirling the flask.
If the solution did not become cloudy the magnesium chloride addition
was repeated.

The lysate was stored at -20C for 1-24 h.

DNA was collected by centrifugation for 10 min at

10~000

dissolved ina,minimal volume (less than 5 ml) of 0.25
and dialyzed against TES buffer for 24 h.

~

Precipitated
rpm, reEDTA, pH 8.0

The plasmid DNA was further

purified by dye-bouyant-density centrifugation as described below.
Alternately, following the chloroform-isoamyl alcohol extraction,
the aqueous phase was brought to a final concentration of 0.3 M
sodium acetate by the addition of 0.1 volume of 3.0 M stock solution.
Twice the volume of cold ethanol (-20C) was added to the solution which
was stored at -20C overnight.

The precipitated DNA was collected by

centrifugation at 12,000 rpm for 20 min at -5 C.

After allowing the

centrifuge tube to drain, the pellet was resuspended in 2.0 m1 TES
buffer and prepared for CsCl-EtBr centrifugation.
d.

Humphreys Method
Early in this work concentration of DNA from large lysates was

achieved through use of polyethylene gycol (PEG) precipitation of
cleared lysates (46} prepared from 500 ml cultures.

After the addition

of NaCl to achieve a final concentration of 0.5 M, the lysates were
adjusted to 10% PEG (w/v).

The mixture was dissolved by swirling the

flask, covered and stored overnight at 4 C.
rpm for 10 min pelleted the DNA.

Centrifugation at 10,000

After discarding the

supernatant~
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the pellet was resuspended in a minimal volume of TES buffer and
purified by CsCl-EtBr centrifugation.
10.

Agarose Gel Electrophoresis
Plasmid DNA prepared by the Guerry-Meyers method described above,

was subjected to electrophoresis in 0.7% agarose (SeaKem, Inc.) dis··
solved in Tris borate buffer (89.0 mM Tris base, 2.5 mM EDTA, 89 mM
boric acid) (71).

To each sample, 5

~1

of dye solution (0.07%

bromophenol blue, 7.0% SDS, 33% glycerol in dH 0) was added prior to
2
electrophoresis.

A horizontal slab gel apparatus (20 x 20 em) with

wells 1 mm x 12 mm x 7 mm deep was used.

The electrophoresis was

carried out at 60 mA, 120 V for 3-4 h or until the dye had travelled
10-12 em.
{0.5

~/ml

The gel was placed in a solution of ethidium bromide
in dH o) and stained for 15 min.
2

The DNA bands, illuminated

by a near UV (366 nm) transilluminator (UV Products, Inc.) were
photographed with a Polaroid MP4 camera using type 57 film and UV 17
and type 21 filters.
11.

Cesium-Chloride-Ethidium Bromide Density Centrifugation
Purification of plasmid DNA was schieved by subjecting the par-

tially purified DNA to cesium chloride-ethidium bromide (CsCl-EtBr)
equilibrium density gradient centrifugation (28, 132).
7.0 ml of the DNA in TES buffer was added to 7.3 g CaCl.

In the dark,
To this

0.6 ml EtBr (10 mg/ml in TES buffer) was added and the refractive
index adjusted to 1.392.

If PEG or sodium acetate was used to pre-

cipitate the DNA, the refractive index was adjusted to 1.3925 or 1.3940
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respectively,

The solution was placed in a polyallomar centrifuge

tube (Beckman), topped with mineral oil, capped and centrifuged to
equilibrium (48 - 72 h, Beckman L-4 or L-5-65 ultracentrifuge, 40
rotor, 35,000 rpm, 20 C).
Following centrifugation, bands of DNA were visualized using
ultraviolet light.

The larger upper band contained linear chromosomal

DNA, and the smaller lower band contained the supercoiled plasmid DNA
which bands at a greater density than the linear form.

The plasmid

DNA was removed either by side puncture of the tube using an 18 guage
needle attached to a 3 cc syringe or by aspiration of the oil and
upper band by mild vacuum and removing the remaining plasmid band
using a pasteur pipette with the tip cut off.

Ethidium bromide was

removed by extracting the DNA solution several times with isopropyl
alcohol saturated with 20X

sse.

Cesium chloride was removed by over-

night dialysis against TES buffer.

In most cases the plasmid DNA was

repurified by a second centrifugation in CsCl-EtBr.
Cesium chloride-ethidium bromide density gradients containing

(~)-DNA were fractionated by bottom puncture of the centrifuge tube.
Fractions containing 15-18 drops each (approximately 0.15 ml) were
tested for the presence of radioactivity by spotting a S
of each onto Whatman filter strips.

~1

sample

The strips were dried, washed

twice in 5% trichloroacetic acid (TCA) for 5 min, and twice in 95%
ethanol for 5 min.

The strips were cut to divide fraction samples

and each was placed into a scintillation vial containing 10 ml
scintillation cocktail (Toluene-Liquifluor, NEN).

Radioactive counts
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were determined in a Packard Tri-Carb Liquid Scintillation Spectrometer.
When plasmid DNA was present peaks were seen.

The first dense peak

containing the plasmid DNA fractions was collected and subjected to a
second CsCl-EtBr centrifugation for further purification.
12.

Sucrose Gradients
a.

Alkaline Sucrose Gradients
Solutions of ( 3H)-labelled plasmid DNA (0.1 ml) were layered

onto 5.0 ml 5-20% linear alkaline sucrose gradients (0.5 M NaCl, 0.3 M
NaOH, 0.2 M EDTA, pH 8.0) in cellulose nitrate centrifuge tubes
(Beckman).

The gradients were centrifuged for 30 min at 35,000 rpm

(Beckman L-5-65 ultracentrifuge, SWSO.l rotor).

Approximately 35

fractions (7 drops each) were collected from the bottom of the tube
directly into scintillation vials containing 1.0 m1 of 1

~

phosphate

buffer and 10 ml Beckman Redi-Solv-scintillation cocktail was added
to each vial.

Each sample was counted for radioactivity as described

above.
b.

Neutral Sucrose Gradients
For analytical purposes, samples of ( 3H)-DNA were overlayered

onto 5 ml linear neutral sucrose gradients (0.55 M NaCl, 0.05
Tris-HCl, 0.005

~

EDTA, pH 8.0).

~

The gradients were centrifuged for

120 min at 35,000 rpm (Beckman L-5-65 ultracentrifuge, SW50.1 rotor),
fractionated, and radioactivity determined as described above, except
for the exclusion of the 1.0 ml of phosphate buffer.
Preparative linear 5-20% neutral sucrose gradients were used to
separate and purify plasmid DNA.

Samples of DNA (1.0 ml) were layered
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onto 11 m1 5-20% neutral sucrose gradients in 12 ml polyallomar
centrifuge tubes and centrifuged in a SP269 swinging bucket rotor at
30,000 rpm, 140 min in an IEC-B60 centrifuge.

A bottom dripper was

used to divide the gradients into 18 drop fractions.

A5

~1

sample

of each fraction was spotted onto filter strips, precipitated with TCA,
rinsed in 95% ethanol, dried and counted as previously described.
Fractions containing plasmid DNA were pooled, dialyzed against TES
buffer and recentrifuged in 12 m1 neutral sucrose gradients.
13.

Quantitation of DNA
Samples of DNA were quantitated by determining their absorbancy

at 260 nm.

Plasmid DNA samples were diluted 1:20 in O.lX sse and

placed in quartz spectrometer tubes.

The absorbance at 260 nm, de-

termined using a Gilford UV spectrometer, was equal to the concentration of the undiluted DNA in mg/ml.
14.

Electron Microscopic Analysis of Plasmid DNA
A modification of the Kleinschmidt technique (51) was used to

prepare the DNA for examination in the electron microscope (EM).

To

prepare the 400 mesh EM grids, they were first placed on a stainless
steel screen set in a large funnel containing double distilled
deionized water (ddH

o).

2

A drop of parlodian dissolved in ethanol

was allowed to spread over the water surface and was then lowered onto
the screen by slowly releasing the water through the bottom of the
funnel.

The parlodian coated grids were incubated at 60 C for 15 min

and cooled.

Prior to each use, a fresh stock of spreading solution
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contain~g

5

~1

in ddH 0) and 40
2

of 1,0 M ammonium acetate, 10
~1

pH 8,0 was prepared,

~1

DNA sample (approximately 1

cytochrome C (10 mg/ml

~g)

in 0,01 M Tris-Hcl

The stock staining solution, which contained

0.05 M HCl and 0,05 M uranylacetate in 95% ethanol, was

~ade

fresh

each week.
The DNA was spread using an acid-cleaned microscope slide soaked
in hypophase (0.25 M ammonium acetate).

The slide was partially sub-

merged in a petri dish containing hypophase and allowed to dry.
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~1

A

drop of spreading solution containing the DNA was gently deposited

onto the slide one-eighth inch above the meniscus and allowed to spread
over the hypophase for 60 sec.

By touching the film side of the grid

to the surface of the hypophase near the slide, a drop-containing DNA
was collected on the grid.

The grid was immediately submerged in the

staining solution for 30 sec, washed in isopentane for 10 sec, and air
dried.
Contrast was enhanced by rotary shadowing using 3 em of 80:20
platinum:palladium 8 mil wire wrapped around a tungston wire of 0.025
em diameter.

The grids were viewed through the RCA electron microscope

at Hines V. A. Hospital.
The images of the electron-micrograph negatives were projected
through a photographic enlarger onto newsprint and traces.

Projection

enlargement was determined by projecting a centtmeter rule at the same
focal length.

The contour length of each molecule was determined by at

least two measurements with a map ruler.

A standard EM grid (#1002

having 2159 intervals per mm) was used to determine the magnification
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of the electron microscope.

A typical grid photograph measured 27 mm

per 8 intervals, thus the magnification of this grid was calculated to
be 7287.

The measured contour length of the molecule divided by the

total magnification (7287 X the magnification of the projected image)
equaled the true length of the plasmid molecule in microns.

Molecular

mass in daltons was calculated by multiplying the length of the
molecule by the constant 2.07 (59).

CHAPTER III

RESULTS
1,

Resistance Phenotype
Proteus mirabilis 2138 is a clinical isolate from the urine of a

patient

~t

Hines Veterans Administration Hospital at Hines, Illinois.

The resistance to various antibacterial agents of this strain was
determined by the Kirby-Bauer disk diffusion technique as described
in Materials and Methods.

The strain was found to be resistant to

ampicillin, carbenicillin, gentamicin, tobramycin, neomycin, kanamycin,
streptomycin, tetracycline, colistin, cephalothin and nitrofurantoin,
and sensitive to naladixic acid, rifampicin, and chloramphenicol.
2.

Transmissibility
To determine if resistance to beta-lactam and aminoglycoside anti-

biotics in strain 2138 resided on a conjugable plasmid, a mating using
Escherichia

£211

J53-1 as recipient was performed.

To select against

the Proteus donor, the genetically characterized strain J53 was made
resistant to rifampicin (200 ].lg/ml) by selection on medium containing
increasing concentrations of that drug as described in Materials and
Methods.

This strain, J53-1, was used in subsequent experiments.

Minimal medium plates containing methionine, proline, rifampicin (200
j.lg/ml), and either carbenicillin (100 ].lg/ml) or gentamicin (50 J.lg/ml)
were used to select transconjugates,

Use of the standard overnight

broth conjugation procedure described in the Methods section failed to
demonstrate transfer of antibiotics resistance to the recipient.
4.7
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to increase cell to cell contact and hence the probability of
conjugation, the donor and recipient cells were concentrated onto
Millipore filters as described (see Materials and Methods).

Using

this method transfer of antibiotic resistance traits was achieved.
The frequency of conjugation on filteiS, calculated as the number of
transconjugates per input donor cells, averaged 1.4 x lo-2 with a
range of 1.3 to 1.5.

There was no significant difference in frequency

of transfer between cells selected on carbenicillin-c9ntaining plates
and those selected on gentamicin-containing plates.
Ten strain J53-l transconjugate clones, numbered J53-l(Pl)J53-l(Pl0), were checked for purity and found to be auxotrophic for
methionine and proline.

To determine if more than one resistant

trait had been transferred, antibiotic disk diffusion tests were performed on five transconjugate clones from each of the two selective
media employed.

The results, shown in Table III, confirm that multiple

resistance had been transferred to all clones tested.

Resistance to

Ap, Cb, Gm, Tm, Km, Sm, and Cl was transferred to both groups of
transconjugates.

However, in no case was resistance to Nm, Tc or Cs

ever observed to transfer.

Given the cross-reactivity of most animo-

glycoside inactivating enzymes, it is interesting to note that resistance to kanamycin was transferred, but not to that of the closely
related antibiotic, neomycin.
To achieve a more precise measure of the level of resistance to
these antibiotics, the minimal bactericidal concentrations (MBC) were
determined as described in Materials and Methods.

The MBCs of am-
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Table III,
Antibiotic resistance patternsa of donor, recipient
and transconjugate strains.

Strain

Antibioticb

No. of isolates

P. mirabilis 2138

Ap Cb Gm Tm Km Sm Cl Tc Cs Nm

1

E. coli J53-l

~

1

E.

~

a

Determined by the disk diffusion technique (69)

b

Ap - ampicillin, Cb - carbenicillin, Gm - gentamicin, Tm - tobramycin, Nm - neomycin, Km - kanamycin, Sm - streptomycin, Tc tetracycline, Cs - colistin, Cl - cephalothin, ~ - rifampicin.

J53-l(Pl)

Ap Cb Gm Tm Km Sm Cl Rm

10/10
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picillin, gentamicin, tobramycin, neomycin, kanamycin and streptomycin were determined for strains 2138, J53-l and the 10 transconjugates.

The results, shown in Table IV, reveal high levels of re-

sistance to Ap, Cb, Gm, Tm and Sm for both the donor strain 2138 and
the 10 transconjugate clones.
strain J53-l.

Values were very low for the recipient

Variations of one tube dilution were seen in the MBC

values of the trarisconjugates.

It is uncertain why the MBC of Sm for

2138 and the transconjugate strains differ.

It is possible that the

donor has inherent resistance properties which are not transferred.
A difference of one tube dilution is not thought to be significant
(37).

Resistance to high concentrations of antibiotics is indicative

of R plasmid-mediated resistance (76).

Again the lack of transfer of

neomycin resistance was clearly evident, despite the high level of resistance in the donor.
3.

Isolation of Extrachromosomal DNA
The fact that resistance to high concentrations of antibiotics

could be transferred to a sensitive strain, indicated that an R plasmid
was involved.

Definitive proof of the existance of plasmids can be

obtained through isolation of the plasmid DNA by ultracentrifugation
(91).

To determine if drug resistance was conferred by an R plasmid_,

the Proteus donor, J53-l recipient and J53-l(Pl) transconjugate were
analyzed for plasmid DNA using the Helinski method for partial purification of plasmid DNA followed by cesium chloride-ethidium bromide
density centrifugation (see Materials and Methods).
centrifuged for 72 h at 32,000 rpm as described.

The gradients were

Viewed under UV

illumination, satellite DNA bands were visible in the gradients from
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Table IV.
Minimal Bactericidal Concentrations a for donor, recipient
and transconjugate strains.

MBC ( llg/ml)b

Strain

P. mirabilis 2138

E. coli J53-1
Transconjugatesc
J53-l(Pl)
J53-l(P2)
J53-l(P3)
J53-l(P4)
J53-l(P5)
J53-l(P6)
J53-l(P7)
J53-l(P8)
J53-l(P9)
J53-l(Pl0)

a

Ap

Cb

Gm

>2000

>2000

500

500

>1000

>2500

>2000

~8

<8

2

<8

<8

20

<8

>2000
>2000
>2000
>2000
>2000
>2000
>2000
>2000
>2000
>2000

>2000
>2000
>2000
>2000
>2000
>2000
>2000
>2000
>2000
>2000

500
250
250
250
250
250
250
250
250
250

500
250
500
250
250
250
250
500
500
500

1000
1000
500
1000
500
1000
500
500
1000
1000

625
625
313
313
313
313
313
313
313
313

<8
<8
<8
<8
<8
<8
<8
<8
<8
<8

Tm

Km

Sm

Nm

Determined by tube dilution technique.

b

Abbreviations are as noted in Table III.

c

J53-l(Pl) - J53-l(P5) selected on medium containing 50 llg/ml Gm,
J53-l(P6) - J53-l(Pl0) selected on medium containing 100 llg/ml
Cb as described in the Results section.
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the donor and transconjugate, but not in the recipient (data not shown).

re

isolate R plasmid DNA, cells were grown in the presence of

(la)-thymtdtne as described in the Methods section, lysed by the
Helinski method and the partially purified radiolabelled DNA was
centrifuged to equilibrium in CsCl-EtBr gradients.

The gradients were

fractionated from the bottom and 0.01 ml samples of each fraction were
spotted on filter strips.

Following TCA

precipit~tion,

radio-

activity was determined as described in Materials and Methods.

Pro-

files of the gradients, shown in Figure l, demonstrate the presence of
dense satellite DNA in strains 2138 and J53-l(Pl), where none could be
seen in strain J53-l.

The presence of the two peaks in the CsCl-EtBr

gradient profile confirmed the visual data described above.

The con-

comitant acquisition of antibiotic resistance and extrachromosomal DNA
provided evidence for the existence of a conjugable R plasmid in P.
mirabilis 2138.
4.

Molecular Characterization of the Plasmid
a.

Determination of Plasmid Size
The most accurate molecular mass determinations of plasmid

molecules have come from measurement of the contour length of the molecules taken from electron micrographs (43).

Preparative (500 ml)

cultures of strains 2138 and J53-l(Pl) were lysed according to the
Helinski method.

To enhance the yield and concentrate the DNA, the

lysates were precipitated with PEG as described in Materials and
Methods, and centrifuged to equilibrium in CsCl-EtBr gradients.
plasmid bands were extracted from the gradients and purified by a

The
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Figure 1. Cesium chloride-ethidium bromide
centrifugation profiles of DNA isolated from donor
recipient and transconjugate strains. Helinski
cleared lysates of P. mirabilis 2138, E. coli
J53-l and E. coli J53-l(Pl) were centrifuged to
equilibrium at 20 C, using a fixed angle 40 rotor
in a Beckman L5-65 ultracentrifuge for 60 h at
35,000 rpm. The gradients were fractionated from
the bottom and radioactivity determined as described in Materials and Methods. (A) P. mirabilis
2138. (B) E. coli J53-l (C)!· coli J53-l(Pl).
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second·centrifugation in CsCl-EtBr.

The purified plasmid DNA was

removed and prepared for electron microscopy using the method of
Klei.riscbm:ldt as desct':lbed in the Materials and Methods section •

.

iypical electronmicrographs are shown in Figure 2.

Contour

length measurements revealed the presence of at least two size classes
of molecules in strain 2138 and only one in strain J53-l(Pl).
cu1ar mass distributions of the plasmids are shown in Figure 3.
mids from strain 2138 were found to be 4.96
megadaltons (Figure 3A).

± 0.05

The molePlas-

and 25.82 + 2.82

The single size class found in strain J53-l

(Pl) measured 89.76 + 2.23 megadaltons (Figure 3B).
Existence of dissociated R plasmids in Proteus species has been
well documented (11, 36, 93, see Introduction).

If this were the case

in strain 2138, the large plasmid found in J53-l(Pl) could be a trimer
of the 27 megadalton plasmid found in strain 2138.

Further elucidation

of the molecular nature of these plasmids was needed to determine the
relationship between them.
b.

Neutral Sucrose Gradients
To determine whether the small and large Proteus plasmids

represented r-determinants and RTF replicons respectively, it would
be necessary to isolate them individually and use the DNA to transform
sensitive strains.

Neutral sucrose gradients provide an effective

means of separating plasmids on the basis of their molecular mass, and
were used to separate the plasmids present in strains 2138 and J53-l(Pl)
Large cultures {500 ml) of strains 2138 and J53-l(Pl) were grown
as described previously.

Additionally, 30 ml cultures of each strain
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Figure 2. Electronmicrographs of plasmids isolated
from donor and transconjugate strains. The Helinski
lysis technique followed by dye-bouyant density
centrifugation was used to isolate DNA from P.
mirabilis 2138 and E. coli J53-l(Pl). The isolated
DNA was prepared for electron microscopy by the
Kleinschmidt method (see Materials and Methods
section). (A) P. mirabilis 2138 (B) E. coli J53-l(Pl)
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Figure 3. Molec'\llar mass distributions of plasmid
molecules isolated from P. mirabilis 2138 and E.
coli J53-l(Pl). Plasmid-DNA was isolated using the
Helinski cleared lysate technique, purified by
equilibrium gradient centrifugation in cesium chloride-ethidium bromide and prepared for electron
microscopy using the method of Kleinschmidt (see
Materials and Methods). Contour length measurements
of electron micrographs were converted to molecular
mass using the equation: Mass • 2.07 x llm. (A)
P. mirabilis 2138 plasmid DNA. (B) E. coli J53-l(Pl)
plasmids DNA.
- --
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were grown in the presence of ( 3H)-thymidine as described in Materials
and Methods.

The cells from both cultures were combined and lysed by

the Helinski method followed by PEG precipitation.

A 0.1 ml sample of

the isolated plasmid DNA, twice purified in CsCl-EtBr gradients, was
overlayed onto a 5 ml analytical 5-20% linear neutral sucrose gradient
and centrifuged at 35,000 rpm for 150 min (see Materials and Methods
section).

The sucrose gradient profiles are shown in Figure 4.

As

expected the presence of one fast sedimenting plasmid was seen in the
profile of plasmid DNA from strain J53-l(Pl) (Figure 4A).

However, the

profile of plasmid DNA from strain 2138 (Figure 4B) was not as clear.
At least three peaks could be distinguished in the gradient, but the
data was irreproducible.

The existenance of several diffuse peaks

were seen in later gradients.
c.

Alkaline Sucrose Gradients
Initially it was thought that the poor resolution of the

Proteus gradient was due to breakage during the extraction and isolation, resulting in nicked open circular or broken linear fragments
of the plasmid DNA.

These species would sediment at different rates

and could account for multiple, nonreproducible peaks in neutral
sucrose gradients.

Alkaline sucrose gradient sedimentation causes

denaturation of nicked and linear forms of DNA.

Since supercoiled

DNA will sediment 3.8 times faster than the denatured forms in alkaline sucrose gradients (pH 12.5) (100), the number and size of
resident plasmid species within the Proteus- strain could be determined.
Radiolabelled plasmid DNA from strains 2138 and J53-l(Pl) was isolated
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Figure 4. Neutral sucrose gradient profiles of
plasmid DNA from strains J53-l(Pl) and 2138. The
DNA samples were isolated by the Helinski method,
twice purified in cesium chloride-ethidium bromide
gradients and overlayered on a 5-20% linear neutral
sucrose gradient in a SW50.1 rotor. The gradients
were centrifuged at 20 C, 35,000 rpm for 2.5 h as
described in Materials and Methods. (A) Strain
J53-l(Pl). (B) Strain 2138.
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using the Cur;r;t.er method and subjected to alkaline sucrose gradient
sedimentation as described in Materials and Methods.

The gradient

profiles from strain -2138, shown in Figure 5, revealed the presence
of the two plasmids seen in electronmicrographs as well as the
presence of a third, fast sedimenting DNA-species.

This suggested that

a third plasmid was present in strain 2138, but had not been isolated
in quantity using the Helinski lysis technique.
d.

Isolation of the Large Plasmid
The Currier plasmid isolation technique was employed for its

usefulness in isolating large plasmids having molecular mass in excess
of 60 megadaltons (15).

Large (500 ml) cell cultures were combined

with 30 m1 cultures of cells grown in the presence of ( 3H)-thymidine,
lysed and subjected to the Currier plasmid isolation technique as
described in Materials and Methods.

Dye-bouyant centrifugation of the

DNA revealed the presence of satellite bands from lysates of strains
2138 and J53-l(Pl), but not in strain J53-1.
plasmid transfer had

occu~red

This reaffirmed that

between donor and recipient strains.

It was found that a modification of the Currier method (see Materials
and Methods) using sodium acetate and ethanol to precipitate the DNA
greatly enhanced the yield of plasmid DNA.

Figure 6 shows the CaCl-

EtBr gradient profiles of strain 2138 and J53-l(Pl) using this
technique,

The plasmid fractions were pooled, rebanded in CsCl-EtBr

gradients and prepared for sucrose gradient sedimentation,
rhe analytical sucrose gradient sedimentation profiles of plasmid
DNA from strains 2138 and J53-l(Pl) isolated using the modified
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Figure 5. Alkaline sucrose gradient profiles of
plasmid DNA from strains 2138 and J53-l(Pl). The DNA
samples were isolated by the Currier method and purified by centrifugation in cesium chloride-ethidium
bromide density gradients. The isolated plasmid DNA
samples were layered on 5-20% alkaline (pH 12.0)
sucrose gradients and centrifuged in a SW50.1 rotor,
35,000 rpm for 0.5 h. Fractions were collected from
the bottom and analyzed as described in Materia~s and
Methods. (A) Strain J53-l(Pl). (B) Strain 2138.
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itgure 6, Cesium chloride-ethidium bromide profiles
of purified plasmid DNA from strains 2138 and J53-l(Pl).
Plasmid DNA was isolated using the Currier technique
and purified by cesium chloride-ethidium bromide
density centrifugation. The CsCl-EtBr gradients were
centrifuged, fractionated and analyzed as described
for Figure 1. (A) Strain J53-l(Pl). (B) Strain 2138.
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Currier technique are shown in Figure 7.

One peak was seen in the

strain J53-l(Pl) gradient (Figure 7A), while three, clearly distinguishable peaks were seen in the strain 2138 plasmid DNA gradient
(Figure 7B).

The slowest sedimentating peak was labelled peak I, the

middle as peak II, and the fastest as peak !II.
e.

Separation of Proteus plasmids
Preparative neutral sucrose gradients were employed to

isolate and separate the three Proteus plasmids in quantity.
cells were

g~pwn

The

as before and subjected to the modified Currier

plasmid isolation technique.

Plasmid DNA was centrifuged in CsCl-

EtBr gradients twice and prepared for neutral sucrose gradient sedimentation.

A 1.0 sample of purified DNA was overlayered on a 12 ml

linear 5-20% neutral sucrose gradient, and centrifuged at 30,000 rpm
in a SP269 swinging bucket rotor for 140 min (see Materials and
Methods).

The gradients were fractionated by bottom puncture and

radioactivity in each fraction determined as described.

Fractions of

each plasmid peak were pooled and centrifuged separately in a second
sucrose gradient.

The three Proteus plasmids were collected as

described in Materials and Methods and used for further study.
f.

Determination of Plasmid Size
Electron micrographs of the largest (peak III) Proteus

plasmid isolated by neutral sucrose gradient sedimentation, were taken
and used to size this plasmid species.
Figure 8.

A typical picture is shown in

The molecular mass, calculated from the contour length
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Figure 7. Neutral sucrose gradient profiles of plasmid
DNA isolated from strains 2138 and J53-l(Pl). Plasmid
DNA isolated by the Currier method was purified by two
centrifugations in cesium chloride-ethidium bromide
gradients, collected and prepared for neutral sucrose
gradient sedimentation as described in the Materials
and Methods section. The 12 ml sucrose gradients (5-20%)
were centrifuged in a SP269 rotor at 30,000 rpm for 140
min at 20 C and fractionated by bottom puncture. Radioactivity was determined as described in Materials and
Methods. (A) Strain J53-l(Pl). (B) Strain 2138. ·
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Figure 8. Electron micrographs of !· mirabilis 2138
peak III plasmid DNA. Proteus plasmid DNA was isolated
using the Currier technique and purified by cesium
chloride-ethidium bromide centrifugation. The Proteus
plasmids were separated according to mass centrifugation
in neutral sucrose gradients as described in Materials
and Methods. Peak III plasmid DNA was prepared for
viewing under the electron microscope using a modification of the Kleinschmidt method as described in
Materials and Methods. A typical molecule is shown here·
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measurements, was found to be close to that of the J53-l(Pl) plasmid.
The distribution of the measured plasmid molecule is shoWn in Figure
9.

The average molecular mass of the peak III plasmid was determined

to be 90.33 + 2.45 megadaltons.

Compared to a value of 89.87 + 2.23

megadaltons obtained for the plasmid isolated from J53-l(Pl), it was
concluded that these were the same plasmid species.
Electronmicrograph measurements of peak I and peak II plasmid
DNA were consistent with previous measurements of strain 2136 plasmid
DNA.

Peaks I and II plasmid DNA averaged 4.95 and 27.1 megadaltons

respectively.

It was concluded that these were the same plasmid

series seen in Figure 2.
g,

Agarose Gel Electrophoresis
Agarose gel electrophoresis has been used to detect and estimate

plasmid DNA species ranging in molecular mass from 6.0 x 105 to
95 x 10

6

daltons (78).

Isolated plasmid DNA from strains 2138 and

J53-l(Pl) were electrophoresed in horizontal agarose gels as described
in the Materials and Methods section.

The gel, pictured in Figure 10,

reveals the presence of three plasmid species in Proteus and one in
strain J53-l(Pl).

Slots A and H contain

total~·

mirabilis 2138

plasmid DNA and clearly reveal the presence of 3 plasmid species.
plasmid DNA from peak I, seen in slots B and C aligns
fastest migrating plasmid in slot A.

The

with the

Above the chromosomal band in

slot A is the middle sized plasmid which migrates with the peak II
plasmid in slot D.

The peak II plasmid in slot E is not visible,

The

slowest migrating plasmid in slot A aligns with the peak III plasmid
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Figure 9. Molecular mass distribution of peak III
Proteus plasmids. Plasmid DNA isolated from strain 2138
by the Currier method was twice centrifuged in cesium
chloride-ethidium bromide gradients and purified in
neutral sucrose gradients as described in the Materials
and Methods section. The DNA was prepared for electron
microscopy by a modification of the Kleinschmidt method.
Molecular mass was determined as for Figure 3.
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Figure 10. Agarose gel electrophoresis of purified
plasmid DNA isolated from strains 2138 and J53-l(Pl).
Plasmid DNA from strains 2138 and J53-l(Pl) was isolated as for Figure 9. The purified plasmid DNA was
subjected to electrophoresis in a horizontal 0.7%
agarose gel for 4 h at 120 V. The gel was stained
with ethidium bromide (0.5 ~g/ml) for 15 min. Pictures
were taken with a Polaroid MP4 camera using type 57
film under UV illumination. (A) Total strain 2138
plasmidDNA. (B and C) Isolated peak I plasmid DNA.
(D and E) Isolated peak II plasmid DNA. (F) Isolated
peak III plasmid DNA. (G) Isolated J53-l(Pl) plasmid
DNA. (H) Total strain 2138 plasmid DNA.
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in slot F and the J53-l(Pl) plasmid in slot G.

This supports the con-

tour length measurements which showed that the peak III plasmid and
the J53-l(Pl) plasmid were the same size.
5.

Proof that the Peak III Plasmid Confers
a.

Aminoglycoside Resistance

Transformation Experiment
A transformation experiment was devised to determine if the 90

megadalton plasmid (peak III) was responsible for resistance to the
beta-lactam and aminoglycoside antibiotics.

Individual plasmid DNA

species isolated from strain 2138 by CsCl-EtBr centrifugation of
Currier lysates and separated in neutral sucrose gradients were used
as the transforming elements.

A rifampicin resistant clone of

Escherichia coliC, strain Cl200-l (his, met), was selected as recipient because it lacks a restriction system.

The transformation

method of Lederberg and Cohen was followed as described in the
Materials and Methods section, and transformants were selected on
plates containing either 25

~g/ml

gentamicin or 100

~g/ml

carbeni-

cillin.
Only two of the individual plasmid DNA species isolated from
Proteus mirabilis 2138 were found to be capable of transforming strain
Cl200-l to antibiotic resistance.

Both the peak I (4.96 Mdal) and

peak III (90.3 Mdal) plasmids were capable of transforming strain
Cl200-l to carbenicillin resistance.

However, only the latter was

capable of transforming strain Cl200-l to gentamicin resistance.

No

gentamicin or carbenicillin resistant transformants could be isolated

79
using the peak II (26.8 Mdal) plasmid.

The frequency of transformation,

calculated as the number of transformants per imput donor cell, was determined for each plasmid species.

Transformation of Cb resistance

occurred at a much higher frequency using the peak I plasmid donor
(7.2 x 10-4 ) than the peak III plasmid donor (7.3 x 10-8).

Trans-

formation of gentamicin resistance occurred at a frequency of 3.8 x
lo-8.

The ability of the smaller plasmid to transform strain Cl200-l

at a higher frequency than the large plasmid was thought to be either
a reflection'of the size difference between the two plasmids, an
effect of concentration of donor DNA, or a combination of both factors.
Escherichia coli Cl200-l transformants of each plasmid species
were cloned, tested for purity and subjected to antibiotic disk diffusion testing to determine if additional antibiotic resistance traits
had been transferred.

Ten clones from each selection were tested and

the results are shown in Table V.

Peak I transformante demonstrated

resistance exclusively to the beta-lactam antibiotics.

Peak III

transformante selected on medium containing either gentamicin or
carbenicillin showed identical resistance patterns including resistance to Ap, Tm, Km., Sm and Cl in addition to Gm and Cb.
b.

Electrophoresis of Plasmid DNA
To detect the presence of the plasmid DNA in the trans-

formants and to determine if this was the same size species as the
donor plasmid, the strain Cl200-l transformants were lysed, and the
partially purified plasmid DNA samples were subjected to agarose gel
electrophoresis as described in Materials and Methods.

The results,

Table V.
Transformation of

!• coli to antibiotic resistance using

P. mirabilis plasmid DNAa •

Strain

Transforming
DNAb

Selection

P. mirabilis 2138

Resistance patternc

Ap Cb Gm Tin Km Sm Cs Cl Nm Tc

E. coli Cl200-l
-Transformante
Cl200-l
Cl200-1

a
b

c

peak l
peak I

Ap
Gm

Ap Cb
Cl
No transformante detected

Cl200-l
Cl200-l

peak II
peak II

Ap
Gm

No transformants detected
No transformante detected

Cl200-l
Cl200-l

peak III
peak III

Ap
Gm

~CbGmTmKm~
~CbGmTmKm~

cr
cr

Determined by disk diffusion technique (69).
Transforming DNA as described as in Figure 7.
Abbreviations as described in Table III.
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pictured

~n

Figure 11,

jugable R plasmid.

reaff~rm

that the peak III plasmid was the con-

The peak I transformants are shown to have only

one plasmid which migrates with the 4.95 Mdal plasmid found in strain
2138.

The largest Proteus plasmid migrated with that found in the

peak III transformants of strain Cl200-l.

Estimates of the molecular

masses of these plasmids, claculated from their migratory distance in
the gels are consistant with those calculated from contour length
measurements.
The transformation of multiple resistance by the 90.3 Mdal (peak
III) plasmid gave conclusive evidence that this was the plasmid carrying the aminoglycoside determinants and was the conjugable R plasmid
in P. mirabilis 2138.
6.

Nomenclature
To conform with other work being done in our laboratory and with

uniform nomenclature as proposed by Novick et al. (83), the plasmids
found in P. mirabilis 2138 were redesignated as follows:

the 4.95

Mdal (peak I) plasmid has been renamed pFL10020; the 26.8 Mdal (peak
II) plasmid has been renamed pFL10030; and the 90.3 Mdal (peak IIIO
plasmid has been renamed pFLlOOlO.

The transconjugate

!·

coli J53-l(Pl)

has been redesignated as J53-l(pFL10010), the peak III transformants
have been designated as Cl200-l(pFL10010) and the peak I transformants
as

Cl200~l(pFL10020).

Transconjugates from other matings were desig-

nated by the recipient strain followed with the (pFLlOOlO) designation.

tn summary, then, the plasmid pFLlOOlO has been shown to confer
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Figure 11. Agarose gel electrophoresis of plasmid DNA
isolated from E. coli transformants. Peak III purified
plasmid DNA, isolated from strain 2138, was used to transform
E. coli Cl200-l to aminoglycoside resistance. Plasmid DNA
isolated from carbenicillin and gentamicin resistant Cl200-l
transformants was subjected to agarose gel electrophoresis
as described in Figure 10. (A) Strain Cl200-l DNA. (B)
Strain 2138 DNA. (C) Strain Cl200-l peak III transformant
selected f~r gentamicin resistance. (D) Strain Cl200-l
peak III transformant selected for carbenicillin resistance. (E) Strain Cl200-l peak I transformant selected for
carbenicillin resistance. {F) Strain J53-l{pFL10010)
transconjugate DNA.
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on its host bacterium resistance to ampicillin, carbenicillin, gentamicin, tobramycin, kanamycin, streptomycin, and cephalothin.

The

small plasmid, pFL10020, confers resistance to ampicillin, carbenicillin and cephalothin only upon its host cell.

Of the four tested

no resistance traits have been associated with the plasmid pFL10030.
7.

Host Range Studies
The prominence of multiple drug resistance among gram-negative

bacterial isolates from patients at Hines V.A. Hospital has become a
formidible problem (65).

To determine the possible role of pFL10010

in this scheme, the host range of this plasmid was investigated.
Standard conjugation experiments were performed using genetically
characterized members of the Enterobacteriaceae and other gramnegative genera as recipient strains.

If broth matings failed to

demonstrate transfer of the R plasmid from either strain J53-l
{pFLlOOlO) or strain 2138 to the recipient strain, the filter method
was employed as described (see Materials and Methods).

Transcon-

jugates were selected on minimal medium containing either gentamicin
(50

g/ml) or carbenicillin (100

~g/ml)

and the necessary auxotrophic

requirements.
The matings and frequencies of conjugation are shown in Table
VI.

With the exception of Proteus mirabilis Pml5, both Cb and Gm

resistance traits were transferred to the recipients at approximately
the same frequency.
J53-l(pFL10010) to

The R plasmid was readily transferred from strain
~·

coli Cl200-l, Enterobacter cloacae 23355,
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Table Vt.
Host Range Studies

Donor straina

2138

J53-l(pFL10010)

a

Recipient strain

E.
E.
P.
P.

coli J53-1
coli Cl200-l
aerusinosa PA038
vulgaris

E. coli Cl200-l
E. COlacae 23355
s. marcescens 8100
K. pneumonia 27730
s. flexneri Sfl
P. mirabilis Pm15
s. typhimurium TA1637
E. coli CSH-K-12
P. vulgaris 6380
P. aeruginosa PA038
X. tumefaciens B6-806
A. tumefaciens 15955

b
Transfer frequency
Gm selection
Cb selection
1.3
1.3

X
X

-2
10_
10 2

NDC

<10-8
-7
3.0 X 10_
4.4 X 10_5
7
3.1 X 10-8
9.3 X 10-6
3.2 X 10_
5
2.2 X 10-8
2.0 x~O
<10
<lo-8
<lo-8
<10-8
<10-8

1.5 X 10 -2
1.1 x 1o-l
4.5 X 10-7
<10-8
1.8 X 10_-75
5.1 X 10_7
3.1 X 10-8
9.3 X 10_6
3.2 X 10_5
9.3 X 10-8
1.0 X 10
<lo-8
<1o-s
<lo-8
<10-8
<10-8

All matings using strain 2138 were performed by the filter
technique. Those matings using strain J53-l(pFL10010) as
donor were done in broth cultures. (See Materials and Methods
section).

b

Expressed as number of transconjugate colony forming units (CFU)
per ml divided by number of imput donor CFU per ml.

c

ND

-not done.
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Serratia marcescens 8100, Klebsiella pneumonia 27730, Shigella flexneri
Sfl, Proteus mirabilis Pml5 and Salmonella typhimurium TA1637 with
frequencies of conjugation ranging from lo-5 to lo-8.

Transfer of

the R plasmid was not detected in matings between J53-l(pFL10010) and

!· coli CSH Kl2, Proteus vulgaris 6380, Pseudomonas aeruginosa PA038,
or Agrobacterium tumefaciens strains B6-806 or 15955.
Attempts to transfer the R plasmid from strain 2138 could not be
achieved without the use of membrane filters to concentrate the donor
and recipient cells.

Using the filter method, the R plasmid was sue-

cessfully transferred from strain 2138 to
Cl20Q-l, and Pseudomonas aeruginosa PA038.

!· coli J53-l, E. coli
Carbenicillin resistance

only was transferred to Proteus mirabilis Pml5, and no transfer of
antibiotic resistance could be demonstrated with the Proteus vulgaris
6380 recipient.

Most significantly, the transfer of the R plasmid to

!· aeruginosa PA038 expanded the host range of this plasmid beyond the
Enterobacteriaceae.

However, the plasmid was not transferred to the

strains of Agrobacterium which have been shown to accept other broad
host rangeR plasmids (96, 108).
Transconjugates from each mating were examined for their antibiotic resistance phenotype using the disk diffusion technique previously described.

A minimum of 10 clones from each mating were tested

and the results are given in Table VII.

As indicated, some of the re-

cipient strains are inherently resistant to certain antibiotics.

For

example, Serratia marcescens 8100 and Klebsiella pneumonia 27730 are
resistant to ampicillin,

!· mirabilis Pml5 is resistant to tetracycline,

Table VII.
Resistance patternsa of donor, recipient and transconjugate strains.
Strainb

Antibioticc

No. of isolates d

Ap Cb Gm Tm Km Sm Cs Cl Nm Tc
1
P. mirabilis 2138
Ap Cb Gm Tm Km Sm
Cl
Rm
1
coli J53-l(pFL10010)e *
Rm
1
E. coli Cl200-l
Ap Cb Gm Tm Km Sm
Cl
Rm
10/10
Cl200-l(pFL10010)
Pm15
Tc Rm
10/10
ND
-P. mirabilis
NDf
15/15
Pml5(p-FL10010)
Ap Cb Gm Tm Km Sm
Tc Rm
Ap
Km Sm Cs Cl
Tc
10/10
~· aeruginosa PA038 *
PA038(pFL10010)
Ap Cb Gm Tm Km Sm Cs Cl
12/12
Tc
E. cloacae 23355
10/10
10/10
23355(pFL10010)
ApCbGmTmKmSm
Cl
s. marcescens 8100
Ap
Cl
10/10
8100(pFL10010)
Ap Cb Gm Tm Km Sm
10/10
Cl
10/10
~· typhimurium TA1637
10/10
TA1637(pFL10010)
Ap Cb Gm Tm Km Sm
Cl
5/5
ND
!• pneumonia 27730
10/10
27730(pFL10010)
ND Cb Gm Tm Km Sm
Cl
S. flexneri Sfl
5/5
Sfl{pFLlOOlO)
Ap Cb Gm Tm Km Sm
Cl
10/10
a All strains were tested for resistance to Ap, Cb, Gm, Tm, Km, Sm, Cs, Cl, Nm, Tc and Rm by the disk
diffusion method {69).
b Transconjugate strains resulting from matings using strain 2138 as donor are indicted by*. All
other transconjugate strains resulted from matings with strain J53-l{pFL10010).
c Abbreviations as described in Table III.
d Number of clones having this phenotype per total number of clones tested.
e E. coli J53-l{pFL10010) was formerly designated as E. coli J53-l(Pl).
f ND - not done.
- ----

!·
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and

f.

aeruginosa PA038 is resistant to ampicillin, kanamycin, strepto-

mycin, colistin, cephalothin and tetracycline.

As seen in the

original mating between strains 2138 and J53-l, no transfer of resistance to either neomycin or tetracycline was detected.

A resistance

phenotype of Ap, Cb, Gm, Tm, Km, Sm, and Cl was transferred
the transconjugate strains.

~

bloc to

Although the recipient strain!· aeruginosa

PA038 was resistant to five of the antibiotics, the transconjugate
clones showed additional resistance to Cb, Gm, and Tm indicating that
transfer of pFLlOOlO had occurred,
In the mating between strain 2138 and

!· mirabilis PmlS resis-

tance to the beta-lactam antibiotics only was detectable.

However,

the transconjugates resulting from the mating of strains J53-l
(pFLlOOlO) and PmlS demonstrated resistance to the aminoglycoside
antibiotics as well (Table VII).

It is possible in matings with

strain 2138 that the smaller plasmid pFLl0020 could have been mobilized by the transfer of pFLlOOlO, but this would not be detectable by
phenotype.
8.

Plasmid Stability
It was noted during routine passage of stock cultures that some

clones not maintained on medium containing gentamicin lost their resistance to that antibiotic.
jugates was checked by

Plasmid stability in several transcon-

passing clones daily onto fresh NA plates and

testing at two week intervals for Gm and Cb resistance.

One hundred

clones of each strain were tested, and the results are shown in Table
VIII.

From this data it is evident that the stability of the plasmid

Table VIII
Stability of plasmids in transconjugate strains. a

Subclones showing growth (%)
b
Strain

Test •edium:c
No. P.assages:

P. mirabilis 2138
mirabilis Pml5{pFL10010)
coli J53-l{pFL100lO)*
*
!· aeruginosa PA038{pFL10010)
!· coli Cl200-l(pFL10010)
!· flexneri Sfl(pFLlOOlO)
!• marcescens 8100(pFL10010)
!· pneumonia 27730(pFL10010)
E. cloacae 23355(pFL10010)
!• t~~himurium TA1637(pFL10010)

P.
!.

14

28

42

14

Cb
28

42

14

28

42

100
100
100
100
100
100
100
100
100
100

100
100
100
100
100
100
100
100
100
100·

100
100
100
100
100
100
100
100
100
100

100
100
100
95
100
100
26
100
100
100

100
100
100
80
100
100
20
100
100
100

100
100
100
40
100
100
0
100
100
100

100
52
57
97
100
100
0
66
100
100

100
25
6
0
100
100
0
50
100
100

100
0
0
0
100
'100
0
50
100
100

Na

a

All strains passed on nutrient agar.

b

Strains derived from matings with strain 2138 are indicated by
from matings with J53-l(pFL10010).

c

NA- nutrient agar, Cb -nutrient agar containing carbenicillin (100
agar containing gentamicin (50 ~g/ml).

Gm

>.·

*·

All other strains derived
~g/ml),

Gm- nutrient
00
1..0
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is a function of the strain in which it is harbored as well as the
nature of the plasmid itself.
the

l~rge

strains:

Gentamicin resistance, carried only on

plasmid, pFLlOOlO, was unstable in five transconjugate
~·

mirabilis Pml5 {pFLlOOlO),

~·

coli J53-l(pFL10010), P.

aeruginosa PA038{pFL10010),

~·

pneumonia 27730(pFL10010).

Carbenicillin resistance which is carried

marcescens 8100{pFL10010) and K.

on both plasmids, pFL10010 and pFL10020, was lost in only two strains:

!· aeruginosa PA038(pFL10010)

and~·

marcescens 8100(pFL10010).

In

both cases loss of Cb resistance was concomitant with the loss of Gm
resistance.

Disk diffusion testing further showed that those clones

which had lost Gm resistance also lost resistance to the other aminoglycoside antibiotics.

CHAPTER IV
DISCUSSION
Infections of the urinary tract with strains of Proteus mirabilis
are common and second only to Escherichia coli infections in the frequency with which they occur (97).

Due to their special predilection

for the upper urinary tract, Proteus infections cause much greater
kidney damage than E.
bladder.

£2!!

infections which are usually limited to the

Proteus mirabilis is now recognized as a frequent nosocomial

pathogen and has been implicated in several nosocomial
fection (9).

ou~breaks

of in-

The increasing number of Proteus clinical isolates re-

sistant to aminoglycoside therapy has become a medical problem (87).
Yoshikawa~~·

(116) have undertaken an extensive study of the

antimicrobial susceptibility pattern of Proteus isolates, and have
shown an increasing occurrence of resistant Proteus strains.

Due to

the cross reactivity of aminoglycoside inactivating enzymes (78, see
Introduction), the efficacy of treatment with those antibiotics has
been greatly reduced.

Since there are only two known enzymes that in-

activate Amikacin, it is now considered the drug of choice for Proteus
infections.

However, the effectiveness of Amikacin may be decreasing

with the increased number of resistant isolates (116).
In this study a Proteus mirabilis clinical isolate (strain 2138)
was shown to be multiply resistant to Ap, Cb, Gm, Km, Nm, Sm, Tm, Cs,
Cl and Tc (Table III).

Analysis of the MBC of these drugs reveals high

levels of resistance, well in excess of obtainable patient serum levels
for each antibiotic.

Such high levels of antibiotic resistance, as
91
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seen in strain 2138, are usually indicative of R plasmids which consitutively synthesize antibiotic inactivating enzymes (78).
The genetic evidence from matings with E. coli clearly show that
the resistance phenotype is due, in part, toR plasmids (Table III).
Resistance to tetracycline was not transferrable and probably reflects
the inherent chromosomal resistance to this antibiotic which is
characteristic of the species (30).

It is unlikely that resistance to

neomycin and tetracycline exist on the large plasmid but are not phenotypically expressed.

Were this the case expression of antibiotic re-

sistance to those drugs should have been seen in at least some of the
transconjugate strains.

Resistance to tetracycline and neomycin was

not detected in any of the transconjugants using the J53-l(pFL10010)
donor.

Given the cross-reactivity of aminoglycoside inactivating en-

zymes, it is interesting to note that neomycin resistance was not
transferred along with resistance to five other antibiotics.
There must be several antibiotic inactivation enzymes in strain
2138, including a beta-lactamase and at least two aminoglycoside inactivating enzymes.

The most common beta-lactamases associated with

plasmids and transposons of gram-negative origin are the TEM-like
enzymes.

Unlike the 0 type, the TEM beta-lactamases have a broader

general activity on penicillins and cephalosporins (39, see Introduction), such as that observed in strain 2138.

A single aminoglyco-

side inactivating enzyme could account for Gm-Tm-Km inactivation (see
Introduction).

Analysis of the substrates of the inactivation enzymes

reveals that more than one enzyme is known to effect Gm-Tm-Km in-
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activation without inactivating Nm.

No enzyme is known to inactivate

any of these three aminoglycosides exclusively, although strain 2138
may carry two or three enzymes which inactivate different combinations
of enzymes.

Since streptomycin inactivating enzymes are specific and

do not cross react with other aminoglycosides, strain 2138 must also
contain a streptomycin inactivating enzyme.

The mechanism of resis-

tance to colistin (Polymixin E) is unknown but it appears not to be
plasmid coded.

Several gram-negative species, including Proteus, are

known to be insensitive to this drug, and the resistance is thought to
be chromosomally mediated (30).
Physical-chemical evidence of the existence of extrachromosomal
DNA in strain 2138 and its transconjugate strain J53-l(pFL10010), came
from isolation of

~lasmid

DNA in CsCl-EtBr density gradients (Figure 1).

Initial isolations using the Helinski lysis procedure led to the detection of two plasmid species in strain 2138, but only one in strain
J53-l(pFL10010).

Contour length measurements of electronmicrographs

showed the molecular mass of the

Prot~us

plasmids to be approximately

5 and 27 megadaltons, whereas the plasmid isolated from the
transconjugate was 90 megadaltons.

.!· ..££.!.!.

Early speculations that the 90 Mdal

plasmid might be dissociated in the Proteus species, or that the transconjugate plasmid was a trimer of the 27 Mdal plasmid were disproven.
The two plasmids isolated from strain 2138 failed to transform
Cl200-l to aminoglycoside resistance.

.!· coli

However, resistance to the

penicillins was transferred by the smaller plasmid.
Analysis of neutral and alkaline sucrose gradients of strain 2138
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plasmid DNA isolated by the Helinski method led to the conclusion that
a third, larger plasmid existed in that species.

The Currier plasmid

isolation procedure was employed for its ability to isolate large plasmids without breakage (15).

Through use of this technique, a 90 mega-

dalton plasmid was isolated from strain 2138.

Comparison of contour

length measurements and migrations in agarose gels revealed that the
large plasmid found in strain 2138 was the same size as the plasmid
isolated from the transconjugate strain J53-l(pFL10010).
The difficulty in isolating the 90 Mdal plasmid from strain 2138
using the Helinski partial lysate technique was most probably due to
its size and to the susceptibility of Proteus to the detergents used to
lyse the cells.

Although the plasmid was recovered from strain J53-l

(pFLlOOlO) using this method, the yield was poor.

The Helinski method

is based on a partial lysis of the bacterial cell wall which allows the
leakage of small plasmid molecules while retaining the larger chromosome.

The Proteus cells were not highly susceptible to the lysis which

explains why only the small molecules were recovered.

The E. coli cells

were extremely sensitive to the lysis which often went to completion
allowing the large plasmid, along with the chromosome, to leak out.
The alkaline sucrose gradients showed that some 90 Mdal plasmid DNA was
present in the Proteus lysates but its detection was initially masked
by the high yields of the smaller plasmids.

The Currier method of

plasmid isolation involves a total lysis of the cells with subsequent
separation of the chromosome from plasmid DNA.

This method was de-

signed for isolation of large plasmids (in excess of 60 Mdal) and
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proved to be effective in this study.

Yields of pFL10010 plasmid DNA

from both strains 2138 and J53-l(pFL10010) were significantly increased
using this method.
Conclusive evidence that the 90 Mdal pFLlOOlO plasmid was the R
plasmid responsible for aminoglycoside resistance comes from the transformation of

~·

££!!

Cl200-l using highly purified and size-fraction-

ated plasmid DNA isolated from strain 2138.

Although the 5 Mdal plasmid

pFL10020 was shown to transform strain Cl200-l to penicillin resistance,
only the pFL10010 appeared capable of transforming strain Cl20Q-l to
aminoglycoside resistance (Table V).

Cells transformed with pFLlOOlO

DNA were found to contain only this plasmid (Figure 1).
The host range studies (Table VI) further revealed that the
pFL10010 plasmid could be transferred in vitro to several strains of
the Enterobacteriaceae and also to the non-Enterobacteriaceae species
Pseudomonas aeruginosa PA038.

However, the frequency of transfer of

the plasmid was low, and could only be achieved through use of the
filter mating technique.

Concentration of donor and recipient cells

by vacuum aspiration onto millipore filters increases eell to cell
contact thus enhancing the probability of plasmid transfer.
ment of this technique did not prove successful in all cases.

EmployNo de-

tectable plasmid transfer was seen between strains 2138 and Proteus
vulgaris 6380, and only carbenicillin resistance was transferred to
Proteus mirabilis Pm15.

In general, Proteus species are considered

poor donors and recipients of R plasmids (24) and several R plasmids
are known to undergo dissociation in this species (see Introduction)".
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However, one would expect an intragenic transfer of R plasmids to
succeed.

The fact that transfer to

~·

vulgaris 6380 using strain

J53-l(pFL10010) as donor also failed is probably a reflection of the
inherent properties of that strain and is consistant with other experiments involving this strain (24).

It is interesting

that~·

miribilis

Pml5 received only the carbenicillin resistance trait when mated with
2138, yet received both Cb and aminoglycoside resistance traits

strai~

when mated with J53-l(pFL10010).

In plasmid stability experiments

gentamicin-resistant clones of strain PmlS(pFLlOOlO} not maintained on
em-containing medium lost their resistance to Gm while retaining Cb
resistance (Table VIII).

It appears that the R plasmid is not stably

maintained by this-strain, and that the Cb-resistance trait can maintain independent existence in this strain.

Since the pFL10020 plasmid

could not have been recieved in matings with J53-l(pFL10010), it seems
likely that the Cb-resistance determinant on the pFLlOOlO plasmid has
transpositional activity, and has integrated into the chromosome or
some indigenous plasmid of strain PmlS{pFLlOOlO).
In addition

to~·

vulgaris 7380, other strains failed to acquire

the R plasmid in broth matings with J53-l(pFL10010).

These include

matings with the non-related species of Agrobacterium tumefaciens and

f.

aeruginosa PA038.

It is interesting that the intragenic mating

between J53-l(pFL10010), a Kl2 derivative, and E. coli CSH-Kl2 also
failed.

Successful transfer of the R plasmid was achieved from strain

J53-l(pFL10010) to E. coli Cl200-l, but only at low frequency of transfer (10~7).

It is possible that t2ansfer to strain CSH-K-12 may have
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occurred, but was below the detectable limits of the experiment (10-8 ),
and would have been enhanced through use of the filter mating technique.
It is possible that phage . I.

could have been liberated from J53-l

(pFLlOOlO) donor and killed the CSH-K12 recipient which does not contain the phage.

However, were this the case, one would have expected

strain CU00-1, which also lacks the phage, to be killed.

It was

later found that the stock cultures of strain CSH-K-12 may have been
contaminated.
The promiscuity of the R plasmid pFLlOOlO is shown by its ability
to transfer to the non-Enterobacteriaceae species Pseudomonas aeruginosa.
Since strain PA038 is intrinsically ampicillin resistant, gentamicin
selection alone was used for the mating.

The disk diffusion tests did

show that the transconjugate strain PA038(pFL10010} did acquire other
resistance traits encoded by pFLlOOlO (Table VII).

Broth matings

between strain J53-l(pFL10010) and PA038 did not yield transconjugates.
However, successful mating was achieved between strains 2138 and PA038
when the filter disk technique was employed.

This indicates that

Pseudomonas is a poor recipient and transferability is only detected
when enhanced by the filter technique.

Of clinical significance be-

yond the broad host range of the R plasmid, is its ability to transfer
at high frequencies to the pathogenic species of Shigella, Salmonella
and Klebsiella.

A multiply resistant plasmid with these capabilities

could present a formidible medical challenge.
As previously mentioned, the R plasmid was not maintained in all

transconjugate clones.

As in the case of P. mirabilis Pml5(pFL10010),
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the strains

~·

coli J53-l(pFL10010) and

~·

pneumonia 27730(pFL10010)

lost Gm resistance while retaining Cb resistance.
Gm and Cb was lost in clones of
marcescens 8leo(pFL10010).

~·

Resistance to both

i·

aeruginosa PA038(pFL10010) and

It is possible that in matings with

strain 2138 the smaller plasmid pFL10020 could be mobilized during
transfer of pFLlOOlO.

The transconjugate strain having pFL10020 would

continue to be Cb resistant even if it lost the larger plasmid.

Since

strain 27730(pFL10010) is the result of a mating using J53-l(pFL10010)
as donor, retention of the Cb resistance trait cannot be explained by
the presence of the plasmid pFL10020 in the transconjugate strain.
It appears that the R plasmid pFLlOOlO contains a Tnt-like
transposon capable of either independent existence of chromosomal
integration.

The size of the Proteus plasmid pFL10020 is consistant

with known Tn1-like transposons (25) which raises the possibility that
this small plasmid may be a dissociated r-determinant derived from the
pFLlOOlO plasmid.
In a hospital environment where the increased use of prophylactic
antibiotics provides a selective pressure, the evolution of multiplyresistant R plasmids is encouraged.

Given the promiscuity of the

plasmid pFL10010, one might envision its evolution to multiple resistance by acquiring resistance traits singly as it was transferred
among various species of bacteria.

The possibility of transpositional

activity of pFL10020 makes this suggestion credible.

The fact that the

R plasmid did not transfer to ~· vulgaris 6380 and only to ~· mirabilis
Pml5 at low frequency suggests that Proteus may not be the original
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host of the R plasmid, and was just the most recent of many hosts in
its evolution.
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